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Welcome to the second Very Low Birth Weight 
Infants in the Republic of Ireland (ROI) Annual 
Report, produced by the Neonatal Intensive 
Care Outcomes Research and Evaluation 
(NICORE) ROI group and facilitated by the 
National Perinatal Epidemiology Centre 
(NPEC).  This report focuses on all babies 
born ≤1500g and/or ≤29 wks gestation in 
the Republic of Ireland for the calendar year 
2015 and compares outcomes to 2014, the 
first year for which we have a complete ROI 
dataset.
Since 2003, nine neonatal centres in the 
ROI have participated in the Vermont Oxford 
Network (VON), the international network 
of health care professionals dedicated to 
improving the medical care of newborn infants 
and which is the entity which underpins this 
report.  The remaining 10 ROI neonatal centres 
joined VON in 2013.  Every neonatal centre in 
the country has submitted data on their very 
low birth weight (VLBW) infants to VON since 
2014.  It is a credit to everybody involved and 
it is truly a great achievement. 
This report, similar to the 2014 report, is 
endorsed by the National Office of Clinical 
Audit (NOCA), as shown in Appendix A. NOCA 
supports institutions and individuals to 
review and action audit findings arising from 
national clinical audit: effectively it aims to 
close the audit loop. The first step in this 
process is to bench mark clinical care with 
identified standards, such as those set by the 
National Clinical Programme in Neonatology 
and the Faculty of Paediatrics. The creation of 
a national dataset of all VLBW infants was the 
first step in this process. The goal, ultimately, 
is to end with implementing change for the 
improvement of patient safety and quality of 
care. On the basis of our first report in 2014, 
the findings of which were reviewed by the 
National Advisory Group of the Royal College 
of Physicians of Ireland (RCPI), the Obstetric 
Working Group of the Health Service Executive 
(HSE) and the Faculty of Paediatrics of the 
RCPI, it was recommended, in view of the small 
numbers of infants involved, that the national 
dataset be reviewed again over a three to 
five year period before any meaningful 
recommendations could be made in the Irish 
context. It was also suggested that an expert 
group looking at the issues surrounding 
infants born at the limits of viability be 
convened under the auspices of the HSE 
Clinical Care Programme in Paediatrics and 
Neonatology.  It is this sort of response and 
support that makes the publication of these 
reports so important. It is truly gratifying to 
see the NOCA vision in action.
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national outcomes became evident.  This was 
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inclusion criteria e.g. in terms of birth weight or 
gestational age, and on the fact that no other 
countries that we are aware of are reviewing 
their data on VLBW infants at a national level. 
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Executive summary
1.  A total of 622 very low birth weight (VLBW) 
infants were born in the Republic of Ireland 
(ROI) in 2015, of which two infants were 
<401g but ≥22 weeks gestation and 
27 infants were >1500g but ≤29 weeks 
gestation.
2.  In all, 224 infants were born with a birth 
weight ≤1000g and 166 infants were born 
with a gestational age ≤26 weeks 6 days.
3.  The survival rate for ROI VLBW infants in 2015 
was 84% (n=525), one percentage lower 
than the rate (85%) for all infants reported 
to the Vermont Oxford Network (VON) in the 
same year.
4.  Adjusting for the risk profile of the VLBW 
population, there was no significant 
difference in the risk of mortality for ROI 
infants compared to VON infants in 2015 
[Standardised Mortality Ratio (SMR)=1.15; 
95% CI: 0.91, 1.39]. In contrast, the mortality 
risk was significantly higher for ROI infants 
in 2014 (SMR=1.27, 95% CI: 1.03-1.51).
5.  Adjusting for the risk profile of the VLBW 
population, there was no significant 
difference in the risk of mortality excluding 
early deaths (deaths in the delivery room 
or deaths within 12 hours of admission to 
the NICU) for ROI infants compared to VON 
infants in 2015 (SMR=1.01; 95% CI: 0.70, 
1.31). This was also the case in 2014. 
6. A significantly higher proportion of ROI 
infants died in the delivery room (7%, n=44) 
compared to VON infants (4%, n=2,304) 
(p<0.001) in 2015. Eleven (25%) of these 44 
ROI infants had a major congenital anomaly 
and a further 28 (64%) were born at less 
than 24 weeks gestation.
7. Despite the above findings that mortality 
and mortality excluding early deaths were 
not significantly different between ROI and 
VON infants, VLBW infants born in the ROI in 
2015 had significantly higher rates of death 
or morbidity (SMR=1.16, 95% CI: 1.03, 1.29). 
This was also the case in 2014 (SMR=1.14, 
95% CI: 1.01, 1.27).
8.  Adjusting for the risk profile of the VLBW 
population, Key Performance Indicators in 
the neonatal care of VLBW infants born in 
the ROI in 2015 compared to VON infants 
showed that:
 • ROI infants had significantly higher rates 
 of pneumothorax (SMR=1.80, 95% CI: 
 1.37, 2.24). This was also reported in 
 2014. 
 • ROI infants had significantly higher rates 
 of coagulase negative staphylococcus 
 infection (SMR=1.60, 95% CI: 1.22, 1.99). 
 This was also reported in 2014.
 • ROI infants had significantly higher rates 
 of nosocomial infection (SMR=1.43, 95% 
 CI: 1.17, 1.69). This was also reported in 
 2014.
 • ROI infants had significantly higher rates 
 of any late infection (SMR=1.44, 95% CI: 
 1.18, 1.70). This was a new finding for 
 2015, although the analogous SMR for 
 2014 was nearly statistically significant 
 (SMR=1.26, 95% CI: 1.00, 1.52).
 • ROI infants had significantly higher rates 
 of IVH (SMR=1.24, 95% CI: 1.05, 1.43). 
 This was a new finding for 2015. However, 
 rates of severe IVH were not significantly 
 different from VON infants (SMR=1.15, 
 95% CI: 0.80, 1.51). 
 • ROI infants had significantly higher 
 rates of necrotizing enterocolitis (NEC) 
 (SMR=1.47, 95% CI: 1.08, 1.86). This was 
 a new finding in 2015.
 • ROI infants had significantly lower rates 
 of retinopathy of prematurity (SMR=0.71, 
 95% CI: 0.53, 0.89). This was also 
 reported in 2014. 
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9.  Of 608 infants with available birth location 
data, 86% (n=342) of those born in tertiary 
neonatal centres; 91% (n=125) of those 
born in regional neonatal centres; and 64% 
(n=45) of those born in peripheral neonatal 
centres survived to discharge.
10. Of 608 infants with available birth location 
data, 7% (n=41) were transferred from their 
birth hospital/neonatal centre within 48 
hours of birth to another neonatal centre or 
tertiary paediatric centre: these included 
1% (n=3) of infants born in tertiary centres; 
1% (n=2) of those born in regional centres; 
and over half (51%, n=36) of those born in 
peripheral centres.
11. Of 48 infants born less than 24 weeks 
gestation in the ROI in 2015, 39 (81%) died 
and nine (19%) survived to discharge: the 
survivors comprised 17% (n=5) of those 
born less than 24 weeks gestation in tertiary 
centres; 20% (n=1) of those born in regional 
centres; and 21% (n=3) of those born in 
peripheral centres.
12. In view of the number of infants involved, it is 
becoming evident that at least three to five 
years of data will be required before a more 
meaningful analysis of the national dataset 
can/should be undertaken. It is hoped to do 
this over the coming years so that specific 
recommendations addressing clinical care 
and patient safety in the Irish context can be 
made.  
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Background
The Vermont Oxford Network (VON) is a non-
profit voluntary collaboration of health care 
professionals dedicated to improving the 
quality and safety of medical care for newborn 
infants and their families. Established in 1988, 
the Network is today comprised of nearly 
1000 Neonatal Intensive Care Units around 
the world (Figure 1).
The Network maintains a database of 
information regarding the care and outcomes 
of high-risk newborn infants. The database 
provides unique, reliable and confidential 
data to participating units for use in quality 
management, process improvement, internal 
audit and peer review.
In the ROI, nine tertiary and regional neonatal 
centres joined VON in 2003, followed by the 
remaining 10 centres in 2013. This was on 
foot of a joint initiative between the NICORE 
(Neonatal Intensive Care Outcomes Research 
and Evaluation) group and the NPEC.  In 2014, 
all 19 neonatal centres in the ROI submitted 
data to VON, signifying the first year for which 
a national dataset is available. The first annual 
report on all VLBW infants born in the Republic 
of Ireland was subsequently published for the 
year 2014. The current report represents the 
second year, 2015, of a complete ROI dataset.
Figure 1: Member countries of the Vermont Oxford Network
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Governance
For the ROI, data submitted to VON are 
controlled by NICORE ROI, a group of 
consultant neonatologists and paediatricians 
with formal representation from all 19 tertiary, 
regional and peripheral neonatal centres in 
the Republic.  NICORE ROI is formally affiliated 
through a Memorandum of Understanding 
to the Faculty of Paediatrics, Royal College 
of Physicians of Ireland (RCPI).  NICORE ROI 
is also formally affiliated to and functions 
in partnership with the National Perinatal 
Epidemiology Centre (NPEC) for the promotion 
and management of VON in the ROI.  
 
NICORE ROI, incorporating all neonatal centres 
in the Republic, collaborates with the five 
neonatal centres in Northern Ireland (NI). 
This cross-border collaboration has been in 
existence since 2003 when only nine centres 
in the ROI were contributing data to VON. The 
collaborative group at that time was identified 
as NICORE Ireland. When all 19 centres in 
the ROI began submitting data to VON, the 
NICORE ROI group was created.  Effectively, 
NICORE ROI is a subgroup of the parent group, 
NICORE Ireland. Figure 2 illustrates all units 
participating in VON in the island of Ireland.
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Figure 2: Neonatal centres in the Republic of Ireland and Northern Ireland participating in the Vermont Oxford Network. ROI 
centres are classified according to number of births weighing 500g or more in the associated obstetric centres in 2015
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Data recording
In 2015, 19 neonatal centres participated 
in the VON’s Very Low Birth Weight (VLBW) 
database.  The definition of eligibility for the 
VLBW database is:
Anonymised data on VLBW infants born 
between 1st January and 31st December 
2015 were submitted to VON’s on-line 
database or alternatively by paper format 
to the NPEC. (Please see Appendix C for data 
collection forms). Figure 3 illustrates the flow 
of information involved. 
On completion of all ROI submissions for 2015, 
VON forwarded a copy of the complete ROI 
dataset to the NPEC.  The data presented in 
this report are based on both the ROI dataset 
and data from “Nightingale”, VON’s on-line data 
reporting system.  Throughout the report, ROI 
data is compared to VON data, comprising data 
from all centres across the Network.
 
Definitions and terminology
Birth weight: Weight from the labour and 
delivery record. If this is unavailable, weight 
on admission to the neonatal unit or lastly, 
the weight obtained on autopsy (if the infant 
expired within 24 hours of birth).
Gestational age: The best estimate of 
gestational age in weeks and days using the 
following hierarchy: 
 • obstetric measures based on last 
  menstrual period, obstetrical 
  parameters, and prenatal ultrasound as 
  recorded in the maternal chart.
 • neonatologist’s estimate based on 
   physical criteria, neurologic examination, 
  combined physical and gestational ages 
  exam (Ballard or Dubowitz), or 
  examination of the lens.
Inborn: Infant delivered at your hospital.
Methods

































Any infant who is born alive at your 
hospital and whose birth weight is 
between 401 and 1500 grams OR 
whose gestational age is between 
22 weeks 0 days and 29 weeks 
6 days (inclusive), regardless of 
where in your hospital the infant 
receives care
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Outborn: Infant delivered outside your 
hospital. Any infant requiring ambulance 
transfer is considered outborn.
Died in the delivery room: Death of a live born 
baby who was never admitted to the NICU, and 
died in the delivery room or at any other location 
in your hospital within 12 hours after birth.
Mortality: Indicates whether the infant died.
Mortality excluding early deaths: Death 
excluding those who died in the Delivery Room 
or within 12 hours of admission to the NICU.
Death or morbidity: Indicates if an infant 
died or was known to have one or more 
of the following key morbidities: severe 
intraventricular haemorrhage (IVH), 
chronic lung disease (CLD) in infants <33 
weeks, necrotising enterocolitis (NEC), 
pneumothorax, any late infection or cystic 
periventricular leukomalacia (PVL). 
Chronic Lung Disease (CLD): Based on an 
algorithm that was tested with hospital data and 
is more accurate than just oxygen dependency 
at 36 wks gestational age.  CLD is coded ‘yes’ 
if the infant is in your centre at 36 weeks 
postmenstrual age and ‘oxygen at 36 weeks’ 
is answered ‘yes’. Infants are considered to 
‘be in your centre at 36 weeks’ if they have not 
been discharged home on that date or if they 
have been transferred from your centre to 
another centre prior to the date of week 36 but 
have been readmitted to your centre before 
discharge home, death or first birthday or are 
not transferred a second time before 36 weeks. 
If the infant is discharged home on or after 
34 weeks postmenstrual age but before 
36 weeks, then CLD is equal to the ‘value of 
oxygen at discharge’. The latter is recorded as 
‘yes’ for infants who went home and were on 
oxygen at the time of discharge.  If the infant 
was transferred to another hospital on or 
after 34 weeks postmenstrual age but before 
the date of week 36, then CLD is equal to the 
‘value of oxygen at the time of discharge’ from 
your institution. Again, the latter is recorded 
as ‘yes’ for infants who were transferred and 
were on oxygen at the time of discharge from 
your centre.  
If the infant is discharged home before 34 
weeks postmenstrual and is not on oxygen 
at the time of discharge, then CLD is coded 
as ‘no’. If the infant is transferred before 34 
weeks postmenstrual age and the infant is not 
on oxygen at discharge, then CLD is coded as 
‘no’. However, if the infant is discharged home 
or transferred to another hospital before 34 
weeks postmenstrual age, and the infant is 
on oxygen at the time of discharge from our 
centre, then CLD is coded as ‘unknown’.
Chronic Lung Disease (CLD) < 33 weeks 
gestation: The same algorithm applied as 
above but only includes infants < 33 weeks 
gestation.  
Pneumothorax: Extra-pleural air diagnosed 
by chest radiograph or needle aspiration 
(thoracentesis).
Late Bacterial Infection: Bacterial pathogen 
recovered from blood and/or cerebrospinal 
fluid culture obtained after day 3 of life. 
Coagulase Negative Infection: Coagulase 
negative staphylococcus recovered from a 
blood culture obtained from either a central line 
or a peripheral blood sample, and/or recovered 
from cerebrospinal fluid obtained by lumbar 
puncture, ventricular tap or ventricular drain 
after day 3 of life AND one or more signs of 
generalized infection AND treatment with 5 or 
more days of intravenous antibiotics. 
Nosocomial Infection: Indicates whether the 
infant has either late bacterial infection and/or 
coagulase negative staphylococcal infection 
diagnosed after day 3 of life. 
Fungal Infection: Fungus recovered from a 
blood culture obtained from either a central line 
or a peripheral blood sample after day 3 of life.
Any Late Infection: Indicates whether the 
infant has either any late bacterial infection, 
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coagulase negative infection and/or fungal 
infection after day 3 of life.
Any Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 
1, 2, 3 or 4 periventricular-intraventricular 
hemorrhage (PIH) on or before day 28.
Severe Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 3 or 
4 periventricular-intraventricular hemorrhage 
(PIH) on or before day 28.
Retinopathy of Prematurity (ROP): Indicates 
whether the infant has stage 1, 2, 3, 4 or 5 ROP.
Severe Retinopathy of Prematurity (ROP): 
Indicates whether the infant has stage 3, 4 or 
5 ROP. 
Cystic Periventricular Leukomalacia (PVL): 
Evidence of cystic periventricular leukomalacia 
on a cranial ultrasound, CT, or MRI scan obtained 
at any time prior to discharge.
Necrotising Enterocolitis (NEC): 
NEC diagnosed at surgery, at post-
mortem examination or “clinically and 
radiographically”. To be diagnosed “clinically 
and radiographically”, there has to be at least 
one of the following clinical signs present: 
bilious gastric aspirate or emesis; abdominal 
distension; occult or gross blood in stool AND 
at least one of the following radiographic 
findings present: pneumatosis intestinalis, 
hepato-biliary air, pneumoperitoneum.
Referenced international comparisons 
The most relevant comparator with which to 
compare outcomes of VLBW infants born in 
the ROI is the VON itself, as the comparison is 
based on identical inclusion criteria and data 
definitions, in addition to constituting the most 
up-to-date data available on VLBW infants. In 
the interests of comprehensiveness, relevant 
publications from the scientific literature have 
also been perused as sources of comparative 
data in this report, however, their inclusion 
criteria and data definitions differ slightly 
from those used in the report and by the VON. 
The following publications are referenced and 
their study populations and inclusion criteria 
are outlined below.
A retrospective cohort study of 58,004 
infants born weighing < 1500g at 24 weeks 
0 days to 31 weeks 6 days gestation and 
admitted to neonatal units of participating 
countries during the period 2007-2010: the 
participating countries were Australia/New 
Zealand, Canada, Israel, Japan, Spain, Sweden, 
Switzerland and the United Kingdom.
• P. Shah, K. Lui, G. Sjörs, L. Mirea, B. Reichman, M. Adams, et al. Neonatal outcomes 
 of very low birth weight and very preterm neonates: an international comparison. J 
 Pediatr, 177 (2016), pp. 144–152.
• Chen F, Bajwa NM, Rimensberger PC, Posfay-Barbe KM, Pfister RE and the Swiss 
 Neonatal Network. Thirteen-year mortality and morbidity in preterm infants in 
 Switzerland. Arch Dis Child Fetal Neonatal Ed 2016: 101: F377-F383. doi:10.1136/ 
 archdischild-2015-308579.
A prospective observational study including 
95% of Swiss preterm infants of gestational 
age < 32 weeks born during three time periods: 
2000-2004, 2005-2008 and 2009-2012.
• Stoll BJ, Hansen NI, Bell EF, et al. Trends in Care Practices, Morbidity, and Mortality 
 of Extremely Preterm Neonates, 1993–2012. JAMA. 2015;314(10):1039-1051. 
 doi:10.1001/jama.2015.10244.
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A prospective cohort study of 34,636 infants, 
born at 22 to 28 weeks’ gestation or birth 
weight of 401 to 1500g, and born at 26 neonatal 
centres in the USA between 1993 and 2012.
A prospective cohort study based on 355,806 
infants whose data was submitted to the 
Vermont Oxford Network and weighing between 
501 and 1500g born in 669 North American 
hospitals in 2000-2009.
A retrospective cohort study of 5341 infants 
from the Canadian Neonatal Network and 9812 
infants from the Neonatal Research Network of 
Japan, born with a birth weight < 1500g from 1 
January 2006 to  31 December 2008.
• Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al. Mortality and 
 neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 
 2012;129(6):1019-26.
• Isayama T, Lee SK, Mori R, Kusuda S, Fujimura M, Xiang YY, et al. Comparison of 
 mortality and morbidity of very low birth weight infants between Canada and Japan. 
 Pediatrics. 2012;130(4):e957-e65.
Reference to Very Low Birth Weight Infants in the Republic of Ireland 
Annual Report 2014 
Reliability of conclusions based on small numbers
Since publication of the 2014 report, some 
values stated in the 2014 report have since 
been updated by individual contributing 
neonatal centres and reported on Nightingale, 
the VON’s internet reporting system. The 
current report utilises the most up-to-date 
values on infants born in 2014 as reported by 
Nightingale and thus some values may differ 
from those stated in the 2014 report.
Population rates and percentages are subject 
to random variation. This variation may be 
substantial when the measure, such as a rate, 
has a small number of events in the numerator 
or denominator. Typically, rates based on 
large numbers provide stable estimates of the 
true, underlying rate. Conversely, rates based 
on small numbers may fluctuate dramatically 
from year to year, or differ considerably from 
one centre to another, even when differences 
are not meaningful. Meaningful analysis 
of differences in rates between geographic 
areas or over time requires that the random 
variation be quantified and that multiple years 
of data be incorporated. In the current report, 
some rates are based on rare outcomes and 
thus have small numbers. It is correct to 
present these rates as this is what the data 
shows, but conclusions cannot be drawn from 
rates and outcomes based on small numbers.
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Main findings
A total of 622 VLBW infants were reported to 
VON in 2015, constituting infants born in all 19 
maternity centres and their affiliated Neonatal 
Intensive Care Units (NICUs) in the Republic of 
Ireland (ROI). A total of 608 VLBW infants were 
reported in 2014.
Table 1.1 outlines the gestational age of infants 
reported in 2015: 48 infants were born <24 
weeks gestation, 114 were between 24 and 
26 weeks gestation, 235 between 27 and 29 
weeks gestation, 170 between 30 and 32 weeks 
gestation, and 55 infants were >32 weeks 
gestation. Table 1.1 also outlines the same 
information for 2014.  In total, 7% (42 out of 
622) of VLBW infants born in 2015 had a major 
congenital anomaly compared to a figure of 9% 
(56 out of 608) in 2014. 
In terms of birth weight, 23 infants weighed 
≤500g, three of whom were ≤401g but ≥22 
weeks gestation (Table 1.2). A total of 100 infants 
had a birth weight in the 501-750g category, 98 
in the 751-1000g category and 155 in the 1001-
1250g category. Overall, 246 infants weighed 
more than 1250g, 26 of whom were ≥1500g 
but were ≤296/7 weeks gestation. Similar data for 
2014 is included in Table 1.2.  
In all, 62,258 VLBW infants were reported to the 
Network in 2015.
1. Overview
Gestational age All cases No. of cases excluding 
  congenital anomalies
 2014 2015 2014 2015
<24 weeks 41 48 40 48
24-26 weeks 117 114 108 103
27-29 weeks 240 235 220 221
30-32 weeks 161 170 142 160
>32 weeks 49 55 42 48
Total 608 622 552 580
Birth weight (g) All cases No. of cases excluding 
  congenital anomalies
 2014 2015 2014 2015
<501 26 23 26 23
501 – 750 86 100 82 95
751 – 1000 116 98 101 84
1001 – 1250 155 155 140 145
>1250 224 246 203 233
Total 607 622 551 580
Table 1.1: Number of cases reported to VON in 2014 and 2015, according to gestational age
Table 1.2: Number of cases reported to VON in 2014 and 2015, according to birth weight 
Note: one infant in 2014 did not have a recorded birth weight
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Table 2.1 summarises the characteristics of 
ROI infants and compares them to those of all 
infants reported to VON in 2015.  
The proportion which was exposed to 
chorioamnionitis; delivered by Caesarean 
section; and was small for gestational age 
(SGA) was the same amongst ROI infants as 
amongst VON infants. The higher proportion 
administered antenatal magnesium sulphate 
in the ROI did not reach statistical significance 
(p=0.076). Characteristics in which there 
were statistically significant differences 
between the two populations, included 
the higher proportion of ROI infants which 
received prenatal care (p=0.005) and the 
lower prevalence of maternal hypertension 
amongst ROI cases (p=0.012). Differences 
which were highly statistically significant 
(defined as a p value<0.001) between ROI 
and VON included the higher proportion of ROI 
infants administered antenatal steroids and 
the higher proportion of multiple gestations 
amongst ROI cases.  
The higher number of major congenital 
anomalies amongst ROI infants in 2015 (7%, 
n=42) compared to VON infants (5%, n=3,297) 
just reached a statistically significant 
difference (p=0.045). In the previous year, 
the difference in rates of congenital anomaly 
between ROI infants (9%, n=54) and VON 
infants (5%, n=3,025) was highly statistically 
significant (P<0.001) (Table 2.2).  
In comparing infant characteristics between 
2014 and 2015, only the proportion receiving 
antenatal steroids was highly significantly 
different between the ROI and VON for 
both years (p<0.001), although the higher 
proportion of ROI infants receiving prenatal 
care (p<0.001 in 2014; p=0.005 in 2015) 
and the higher number of multiple gestations 
amongst ROI infants (p=0.008 in 2014; 
p<0.001 in 2015) was also consistent 
between the years (Table 2.2).
Elsewhere, differences in rates between 
countries have been detected for Caesarean 
section, multiple births and antenatal 
steroids. In the years 2007-2010, the rates 
of Caesarean section in VLBW infants ranged 
from 47% in the UK; 62% in Canada; 64% in 
Australia/New Zealand; 67% in Spain; 72% in 
Sweden; 73% in Israel; 77% in Japan; to 84% 
in Switzerland (1): the ROI rate for both 2014 
and 2015 was 70%. The proportion of multiple 
births was lowest in Japan (24%) and greatest 
in Israel (42%) during the same period: the 
ROI 2015 rate was 36%. Administration of 
antenatal steroids ranged from 49% in Japan 
through to 90% in Australia/New Zealand (1) 
and was 87% in mothers in a study from the 
USA (2): the ROI 2015 rate was 88%.  The 
marginally higher proportion of males born 
in the ROI is reflected in a number of studies. 
(1-3)
Proportions of major congenital anomaly in 
other countries have been reported to be 
2% in the UK; 3% in Israel, Switzerland and 
Sweden; 4% in Australia/New Zealand; 7% in 
Japan and Spain; and 8% in Canada (1) and 
proportions of 5% have been reported in the 
USA and Switzerland (2, 3). The ROI rates for 
major congenital anomaly were 9% and 7% for 
2014 and 2015 respectively.
2. Infant Characteristics
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Table 2.1: Infant characteristics in the Republic of Ireland and VON, 2015. The P-value refers to the significance of the 
value of the difference between the ROI and VON populations.
Table 2.2: Infant characteristics in the Republic of Ireland, 2014 and 2015. The P-value refers to the significance of the 
value of the difference between the ROI and VON populations.
    Republic of Ireland VON 
 Characteristic  Cases N %     N % P-value
Male 336 622 54 62,199 51 0.132
Prenatal Care 608 619 98 61,975 96 0.005
Chorioamnionitis 87 610 14 61,491 13 0.354
Maternal Hypertension 162 616 26 61,851 31 0.012
Antenatal Steroids 542 616 88 61,875 81 <0.001
C-Section 433 622 70 62,211 72 0.185
Antenatal Magnesium Sulphate 359 613 59 60,565 55 0.076
Multiple Gestation 225 622 36 62,245 27 <0.001
Major Congenital Anomaly 42 622 7 62,200 5 0.045
Small for Gestational Age (SGA) 150 622 24 62,102 24 0.946
 2014 2015
 Characteristic  ROI  VON  P-value ROI  VON  P-value 
 % %      % % 
Male 55 51 0.040 54 51 0.132
Prenatal Care 99 95 <0.001 98 96 0.005
Chorioamnionitis 16 13 0.020 14 13 0.354
Maternal Hypertension 25 30 0.014 26 31 0.012
Antenatal Steroids 87 80 <0.001 88 81 <0.001
C-Section 70 71 0.303 70 72 0.185
Antenatal Mag. Sulphate 51 52 0.720 59 55 0.076
Multiple Gestation 33 28 0.008 36 27 <0.001
Major Congenital Anomaly 9 5 <0.001 7 5 0.045
Small for Gestational Age  25 24 0.551 24 24 0.946
Note: N represents all babies for whom the variable applies (the denominator).
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A total of 84% (n=525) of VLBW infants born 
in the ROI survived to discharge home or first 
birthday, one percentage below the VON rate 
(85%, n=52,680) (Table 3.1). The 2015 ROI 
survival rate represents an increase from 
2014 (82%, n=492), whilst the VON survival 
rate dropped by 1% from 86% to 85% between 
2014 and 2015 (Table 3.2). The ROI survival 
rate was not statistically different from the 
VON rate in 2015 (p=0.68). Previous studies 
have obtained survival to discharge rates of 
79% (2) and 86% (3).
The percentages of those who survived 
without specified morbidities in 2015, i.e. the 
key morbidities of severe IVH, chronic lung 
disease in infants <33 weeks gestation, NEC, 
pneumothorax, any late infection or cystic 
PVL was 54% (n=337) in the ROI and 57% 
(n=34,894) in VON, a difference which was 
not statistically significant (p=0.16).  The 
2015 survival without specified morbidities 
rates represent an increase of 1% from 2014 
for ROI infants and no change for VON infants 
(Table 3.2).
Comparisons with other studies highlight 
the variation internationally in survival to 
discharge without specified morbidities. 
For example, the Swiss Neonatal Network 
reporting on survival free of major 
complications (which was defined as 
survival of NICU stay and absence of 
bronchopulmonary dysplasia (BPD), severe 
IVH, NEC and cystic PVL), observed a rate 
of 72% for the period 2009-2012: notably 
these complications did not include severe 
ROP or late infection (3). In a USA study, the 
proportion which survived without the major 
morbidities of NEC, infections (early-onset 
sepsis, late-onset sepsis or meningitis), BPD, 
severe intracranial haemorrhage (ICH), PVL 
and severe ROP was 29% in 2012 (2). Some 
of the variation observed in international 
comparisons is likely due to variable inclusion 
criteria for major morbidities. However, the 
ROI and VON proportions of 54% and 57% 
respectively are comparable to each other.
3. Survival
Table 3.1: Survival of ROI and VON infants, including those with congenital anomalies, 2015. The P-value refers to the 
significance of the value of the difference between the ROI and VON populations.
Table 3.2: Survival of ROI and VON infants, including those with congenital anomalies, 2014 and 2015. The P-value 
refers to the significance of the value of the difference between the ROI and VON populations.
     Republic of Ireland   VON 
 Measure Cases N %   Cases   N % P-value
Survival* 525 622 84% 52,680 61,759 85% 0.68
Survival without specified morbidities** 337 622 54% 34,894 61,759 57% 0.16
  2014 2015
 Measure ROI VON P-value   ROI VON P-value
  % %  % % 
Survival* 82 86 0.01 84 85 0.68
Survival without specified morbidities** 53 57 0.08 54 57 0.16
Note: N represents all babies for whom the variable applies (the denominator).
* Indicates whether the infant survived to discharge home or first birthday
**Denotes severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax, any late infection or cystic PVL.
* Indicates whether the infant survived to discharge home or first birthday
**Denotes severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax, any late infection or cystic PVL.
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Note: In 2014, 8 of 608 infants did not have a valid value for the survival variable, therefore, the denominator for survival is 600.  
Survival to discharge of VLBW infants by 
gestational age and birth weight is reported in 
Tables 3.3 and 3.4 respectively for both 2014 
and 2015. 
Survival to discharge rose with increasing 
gestational age, albeit with some slight 
variation away from this pattern above 
30 weeks gestational age (Table 3.3). The 
Swiss Neonatal Network previously reported 
survival rates of 4% for 23 weeks gestational 
age, 42% for 24 weeks gestational age, 61% 
for 25 weeks gestational age, 85% for 26 
weeks gestational age, 90% for 27 weeks 
gestational age, 92% for 28 weeks, 96% for 
29 weeks, 96% for 30 weeks and 97% for 31 
weeks gestational age during 2009-2012 
(3): the rates are similar to the ROI rates for 
every gestational age except for 23 and 24 
weeks which were lower in the Swiss study. 
A USA study observed survival to discharge 
rates of 9% amongst 22 weeks gestational 
age infants, 33% amongst 23 weeks 
gestational age infants, 65% amongst 24 
weeks gestational age infants, 81% amongst 
25 weeks gestational age infants, 87% 
amongst 26 weeks gestational age and 94% 
amongst both 27 and 28 weeks gestational 
age infants in 2012 (2). These proportions 
are comparable to the ROI 2015 findings, but 
slightly less so in the context of the ROI 2014 
findings (Table 3.3).  
In terms of periviable births (broadly 
defined as 200/7 to 256/7 weeks gestational 
age), reports published since 2000 show 
remarkable variability in survival outcomes 
amongst studies. A summary of such 
studies has demonstrated multiple reasons 
for this variation, some of which include 
non-modifiable factors (e.g. sex and weight, 
singleton birth), modifiable factors (e.g. 
intent to intervene, antenatal corticosteroid 
administration, life-sustaining interventions 
at birth), and study design and reporting 
features (e.g. single-centre, regional, or 
national data; definition of mortality) (4).
Table 3.3: Gestational age breakdown and survival to discharge of ROI infants reported to VON, 
including those with congenital anomalies, 2014 (N=600) and 2015 (N=622)
  2014 2015
Gestational Age Number of Survivors/ Number of Survivors/ 
  No. of liveborn infants (%) No. of liveborn infants (%)
<22 weeks 0/2 (0%) 0/2 (0%) 
22 weeks 0/18 (0%) 0/16 (0%)
23 weeks 4/21 (19%)  9/30 (30%) 
24 weeks 17/35 (49%) 22/34 (65%)
25 weeks 26/36 (72%) 33/43 (77%)
26 weeks 28/43 (65%) 30/37 (81%)
27 weeks 53/56 (95%) 40/46 (87%)
28 weeks 76/84 (90%) 82/90 (91%) 
29 weeks 93/99 (94%) 94/99 (95%)
30 weeks 68/71 (96%) 65/65 (100%)
31 weeks 44/49 (90%) 64/68 (94%)
32 weeks 35/37 (95%) 35/37 (95%)
>32 weeks 47/49 (96%) 51/55 (93%)
Total 492/600 (82%) 525/622 (84%) 
NPEC Very Low Birth Weight Neonatal Care 2015 050517 V2.indd   21 05/05/2017   11:55
22 VERY LOW BIRTH WEIGHT INFANTS IN THE REPUBLIC OF IRELAND ANNUAL REPORT 2015 
Note: In 2014, 8 of 608 infants did not have a valid value for the survival variable and 1 did not have a recorded birth weight, 
therefore, the denominator for survival is 599.  
Table 3.4: Birth weight and survival to discharge of ROI infants reported to VON, including those 
with congenital anomalies, 2014 (N=599) and 2015 (N=622)
  2014 2015
Gestational Age Number of Survivors/ Number of Survivors/ 
  No. of liveborn infants (%) No. of liveborn infants (%)
<501g 2/26 (8%) 4/23 (17%) 
501-600g 8/31 (26%) 19/37 (51%)
601-700g 25/37 (68%) 29/45 (64%) 
701-800g 26/36 (72%) 26/37 (70%)
801-900g 29/37 (78%) 33/40 (83%)
901-1000g 51/58 (88%) 34/39 (87%)
1001-1100g 46/53 (87%) 54/59 (92%)
1101-1200g 58/62 (94%) 58/64 (91%) 
1201-1300g 82/86 (95%) 63/67 (94%)
1301-1400g 68/72 (94%) 84/87 (97%)
>1400g 96/101 (95%)  121/124 (98%)
Total 491/599 (82%)  525/622 (84%)
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There are 19 neonatal centres in the ROI, each 
of which is designated a tertiary, regional or 
peripheral neonatal centre based on both the 
number of births per annum in the affiliated 
obstetric centre and the level of neonatal 
consultant cover in the neonatal centre. There 
are four designated tertiary neonatal centres, 
four designated regional neonatal centres 
and eleven designated peripheral neonatal 
centres (Table 4.1). Each of the tertiary 
centres deliver more than 8,000 births per 
annum and all provide 24 hour consultant 
neonatology cover. The regional centres 
have dedicated neonatal intensive care units 
(NICUs) in their centres but do not have 24-
hour consultant neonatology cover. In 2015, 
one of these four centres delivered between 
4,000-5,000 births per annum; one centre 
delivered between 3,000-4,000 births per 
annum; the third centre delivered between 
2,000-3,000 births per annum; and the fourth 
centre delivered less than 2,000 births per 
annum when births weighing 500g or more 
are counted (Table 4.1). Peripheral centres 
do not have dedicated NICUs nor do they have 
dedicated consultant neonatology cover but 
they do have designated areas for newborn 
infants namely Special Care Baby Units 
(SCBUs). In 2015, all but one peripheral centre 
delivered less than 2,000 births per annum 
and that one centre delivered between 2,000-
3,000 births per annum. 
4. Survival according to designated category of neonatal unit
Source: Irish Maternity Indicator System National Report 2015 (5)
  Hospital Number of births 
Designated Tertiary Neonatal Centres 
 National Maternity Hospital > 8,000
 Coombe Women & Infants University Hospital > 8,000
 Rotunda Hospital > 8,000
 Cork University Maternity Hospital > 8,000
Designated Regional Neonatal Centres 
 University Maternity Hospital Limerick 4,000-5,000
 Our Lady of Lourdes Hospital Drogheda 3,000-4,000
 Galway University Hospital 2,000-3,000
 University Hospital Waterford < 2,000
Designated Peripheral Neonatal Centres 
 Midland Regional Hospital Mullingar 2,000-3,000
 Portiuncula Hospital Ballinasloe < 2,000
 Wexford General Hospital < 2,000
 Midland Regional Hospital Portlaoise < 2,000
 St Luke’s Hospital Kilkenny < 2,000
 Cavan General Hospital < 2,000
 Mayo University Hospital < 2,000
 Letterkenny University Hospital < 2,000
 University Hospital Kerry < 2,000
 Sligo University Hospital < 2,000
 South Tipperary General Hospital < 2,000
Table 4.1: Number of live births and stillbirths weighing greater than or equal to 500g in 
maternity centres in 2015 
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Of 622 VLBW infants reported to VON in 2015, 
608 infants had birth location data suitable 
for analysis of survival outcome according to 
category of designated neonatal centre. Birth 
location data on the remaining 14 infants was 
either unavailable (nine) or the infants were 
born before arrival (five). 
Of the 608 infants with available birth location 
data, 400 (66%) were born in one of four 
tertiary neonatal centres; 138 (23%) were 
born in one of four regional neonatal centres 
and the remaining 70 infants (11%) were born 
in one of eleven peripheral centres (Table 4.2). 
Of the 608 infants, 463 (76%) received 
intensive care/resuscitation in the delivery 
room (defined as the administration of 
face mask ventilation and/or endotracheal 
tube ventilation) (Table 4.2). Intensive care 
was provided to 79% of the infants born in 
tertiary centres, 71% of the infants born in 
regional centres and 70% of the infants born 
in peripheral centres. Of the 463 infants 
requiring resuscitation, 403 (87%) survived 
to discharge. The remaining 60 (13%) infants 
died, eight of whom died in the delivery room 
(Figure 4.1).    
A total of 145 (24%) of the 608 infants did not 
receive intensive care/resuscitation in the 
delivery room, of whom 36 infants died in the 
delivery room and 109 survived to admission 
to a NICU/SCBU (Table 4.3 and Figure 
4.1). These 109 infants were born in good 
enough condition so as not to require active 
resuscitation at birth: 75 of these infants were 
born at greater than 30 weeks gestation, 33 
infants were in the 27 - 29 weeks gestational 
age range, and one infant was in the 24-26 
weeks gestational age range. 
 Category  Resuscitation Died in DR –  Total
 Neonatal  not required Resuscitation 
 Centre   not offered
 Tertiary  65 19 84
 Regional  33 7 40
 Peripheral 11 10 21
 Total  109 36 145
Table 4.3: Survival outcomes of infants who did not receive intensive care/resuscitation in the 
delivery room by category of neonatal centre, 2015
Survival  Tertiary Regional Peripheral Total
 Centres Centres Centres
Number of liveborn infants 400 138 70 608
No. (%) who received resuscitation in the delivery room 316 (79%) 98 (71%) 49 (70%) 463 (76%)
No. who died in DR despite active resuscitation 3  1 4 8
No. (%) admitted to a NICU/SCBU 378 (95%) 130 (94%) 56 (80%) 564 (93%)
No. (%) transferred to another neonatal centre 3 (1%) 2 (1%) 36 (51%) 41 (7%)
within 48 hours of birth
No. survived to discharge  342 125 45 512
% survival to discharge of  liveborn infants 86% 91% 64% 84%
Table 4.2: Survival of ROI Infants by category of neonatal centre, 2015, n=608
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Of the 608 infants with available birth location 
data, 564 (93%) were admitted to a NICU/
SCBU, comprising 378 (95%) of the infants 
born at tertiary centres, 130 (94%) of those 
born at regional centres and 56 (80%) of those 
born in peripheral centres (Table 4.2). These 
included infants who were transferred out 
of the birth hospital and to another neonatal 
centre within 48 hours of birth. A total of 41 
(7%) of 608 infants were transferred and the 
majority of these (88%, n=36) were born in 
peripheral centres. Three infants from tertiary 
centres were transferred out within 48 hours 
of birth, one to another tertiary neonatal 
centre and two to a paediatric hospital. Two 
infants from regional centres were transferred 
out to tertiary neonatal centres.
The overall survival rate of 608 infants 
with available birth location data was 84% 
(n=512): the highest survival rate occurred 
in the regional centres (91%, n=125), followed 
by 86% (n=342) at tertiary centres and 64% 
(n=45) at peripheral centres (Table 4.2 and 
Figure 4.1).
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Figure 4.1: Flow chart illustrating survival outcomes of VLBW infants according to category of neonatal centre, 2015, 
n=608 
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Of 608 infants with available birth location 
data, 48 were infants born <24 weeks 
gestation (which were all of the infants born 
<24 weeks gestation in 2015, all having 
available birth location data). A total of 29 
(60%) were born in one of the tertiary neonatal 
centres; five (10%) in one of the regional 
centres and the remaining 14 (29%) in one of 
the eleven peripheral centres (Table 4.4). 
Twenty-two infants (46%) received intensive 
care/resuscitation in the delivery room (Table 
4.4), including 14 (48%) of the infants born in 
tertiary centres, one (20%) of the infants born 
in regional centres and 7 (50%) of the infants 
born in peripheral centres. Of the 22 infants 
who received intensive care/resuscitation in 
the delivery room, two of these died in the 
delivery room despite active resuscitation. 
Hence 20 infants (42%) survived to admission 
to a NICU/SCBU. 
Of the 26 infants who did not receive intensive 
care/resuscitation in the delivery room, one 
was 20 weeks gestation, another 21 weeks, 
16 were 22 weeks and the remainder (eight) 
were 23 weeks gestation (five of the 16 infants 
born between 230/7 – 233/7 weeks and three 
of the 14 infants born between 234/7 – 236/7 
weeks). All of these infants died in the delivery 
room. None had a congenital anomaly.
Of the 20 infants who survived to admission 
to a NICU/SCBU, one of these infants died 
within twelve hours of admission. This infant 
was born in a tertiary centre. Five infants were 
transferred from their hospital of birth soon 
after birth. All five of these infants were born 
in peripheral centres and all were transferred 
to one of the four tertiary centres. All were 
transferred on Day 2 (i.e. on the day after the 
date of birth irrespective of the time of birth) 
(Table 4.4 and Figure 4.2). 
Of the 19 infants surviving >12 hours, a further 
ten died. In total, nine survived to discharge. 
Therefore, the overall survival rate for infants 
born <24 weeks gestation in the ROI in 2015 
was 19% (n=9/48) which compares to a 
figure of 10% (n=4/41) in 2014. The overall 
survival rate for infants of this gestational 
age increases to 41% if only infants who were 
actively resuscitated  in the delivery room are 
included in the analysis (n=22) and to 45% if 
only the infants who survived to admission 
to a NICU/SCBU are included in the analysis 
(n=20) (Table 4.4). 
In total, 28 (58%) infants born <24 weeks 
gestation died in the delivery room in the 
ROI in 2015. This compares to a figure of 
38% (1,604 of 4,277) for infants born <24 
weeks gestation in the VON population, the 
difference between the two populations being 
statistically significant (p<0.001). In 2014, 
the figures for delivery room death of infants 
born <24 weeks gestation were 88% (n=36) 
for ROI infants and 39% for VON infants, also 
statistically significant (p<0.001). However, 
there has been a significant decrease in the 
number of ROI infants <24 weeks gestation 
dying in the delivery room in 2015 when 
compared to 2014, from 88% to 58% (p<0.001). 
Of the 48 infants <24 weeks gestation, none 
had an associated major congenital anomaly. 
Survival for infants who were transferred 
within the first 48 hours of birth to another 
neonatal centre was 60% (n=3/5).
In summary, of 48 infants born less than 
24 weeks gestation in the ROI in 2015, 39 
(81%) ultimately died and 9 (19%) survived to 
discharge (Table 4.4).
Survival of infants born at less than 24 weeks gestation according to 
category of neonatal centre
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* One infant transferred to a tertiary neonatal centre on Day 81 of life
Survival  Tertiary Regional Peripheral Total
 Centres Centres Centres
Number of liveborn infants 29  5 14 48
No. (%) who required resuscitation in the delivery room 14 (48%) 1 (20%) 7 (50%) 22 (46%)
No. (%) admitted to  a NICU/SCBU 14 (48%) 1 (20%) 5 (36%) 20 (42%)
No. (%) transferred to another neonatal centre  0/29 (0%) 0/5 (0%)* 5/14 (36%) 5/48 (10%)
within 48 hours of birth
No. survived to discharge  5  1 3 9
% survival to discharge of liveborn infants  17% 20% 21% 19%
Survival to discharge of all liveborn infants 36% (5/14) 100% (1/1) 43% (3/7) 41% (9/22)
offered resuscitation
% survival to discharge of all liveborn infants admitted 36% (5/14) 100% (1/1) 60% 3/5 45% (9/20)
to NICU/SCBU
Table 4.4: Survival of ROI Infants born at less than 24 weeks gestation by category of neonatal centre, 2015, n=48
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Figure 4.2: Flow chart illustrating survival outcomes of VLBW infants born <24 weeks gestation according to designated 
category of neonatal centre, 2015, n=48
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Overall, there were 111 infants born at 24-26 
weeks gestation for whom birth location data 
were available. Of these, 80 (72%) were born in 
one of the tertiary neonatal centres, 18 (16%) 
in one of the regional centres and 13 (12%) in 
one of the peripheral centres (Table 4.5).
Of the 111 infants born, 108 (97%) received 
intensive care/resuscitation in the delivery 
room, including 79 (99%) infants born in 
tertiary centres, 17 (94%) infants born in 
regional centres and 12 (92%) of the infants 
born in peripheral centres. Of the 108 infants 
offered intensive care/resuscitation, four 
infants died in the delivery room despite 
resuscitation. One of these deaths occurred 
in a tertiary centre, one in a regional centre 
and two in peripheral centres. The gestational 
age of two of these infants was 240/7 weeks; 
one was 250/7 weeks and the fourth was 
252/7 weeks: one had an associated major 
congenital anomaly.
Three infants did not receive intensive care/
resuscitation in the delivery room. Two of 
these infants had major congenital anomalies: 
one infant had a diagnosis of congenital 
hydrocephalus/myelomeningocoele and the 
other infant, hydrops foetalis and both died 
in the delivery room. The third infant was 
born at 264/7 weeks gestation in a tertiary 
centre and was born in such condition as 
to not require resuscitation in the delivery 
room. 
In all, six (5%) infants born at 24-26 weeks 
gestation died in the delivery room. This 
compares to a figure of 2% (333 of 14,471) for 
infants born at 24-26 weeks gestation who 
died in the delivery room in the VON population, 
a difference which was statistically significant 
(p=0.02). 
A total of 105 (95%) infants born at 24-26 
weeks gestation survived to admission to 
a NICU/SCBU. Eleven of these (10% of those 
liveborn at 24-26 weeks gestation) were 
transferred from their hospital of birth soon 
after birth (Table 4.5). One of these infants 
was born in a tertiary centre; one infant in a 
regional centre, and a further nine in peripheral 
centres (Figure 4.3). All were transferred to 
tertiary neonatal centres within 48 hours of 
birth. One additional infant was transferred 
from a regional centre to a tertiary centre on 
Day 11 of life and therefore is not included in 
the transfer numbers in Table 4.5. Six of these 
eleven infants who were transferred died 
prior to discharge, one of whom was born in a 
tertiary centre and five of whom were born in 
peripheral centres. 
In all, 82 (74%) infants born at 24-26 weeks 
gestation survived to discharge: 79% (n=63) 
of those born in tertiary centres, 78% (n=14) 
of those born in regional centres and 39% 
(n=5) of those born in peripheral centres 
(Table 4.5). 
Outcomes of infants born at 24-26 weeks gestation according to 
category of neonatal centre
* One other infant was transferred to a tertiary neonatal centre on Day 11 of life.
Survival  Tertiary Regional Peripheral Total
 Centres Centres Centres
Number of liveborn infants 80 18 13 111
No. (%) who received resuscitation in the delivery room 79 (99%) 17 (94%) 12 (92%) 108 (97%)
No. (%) admitted to a NICU/SCBU 79 (99%) 16 (89%) 10 (77%) 105 (95%)
No. (%) transferred to another neonatal centre within  1 (1%) 1 (6%)* 9 (69%) 11 (10%)
48 hours of birth
No. survived to discharge  63 14 5 82
% survival to discharge of liveborn infants  79% 78% 39% 74%
Table 4.5: Survival of ROI Infants born at 24–26 weeks gestation by category of neonatal centre, 2015, n=111
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Figure 4.3: Flow chart illustrating survival outcomes of VLBW infants born at 24–26 weeks gestation according to 
category of neonatal centre, 2015, n=111
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Overall, there were 226 infants born at 27-29 
weeks gestation for whom birth location data 
were available. Of these, 158 (70%) were born 
in one of the tertiary neonatal centres, 52 
(23%) in one of the regional centres and 16 
(7%) in one of the peripheral centres (Table 
4.6).  
Of the 226 infants, 191 (85%) received 
intensive care/resuscitation in the delivery 
room, including 134 (85%) infants born in 
tertiary centres, 45 (87%) infants born in 
regional centres and 12 (75%) infants born 
in peripheral centres. Two of these infants 
died in the delivery room despite receiving 
resuscitation, of whom one had a major 
congenital anomaly. Both of these infants 
were born in tertiary centres (Figure 4.4). 
A total of 35 infants did not receive 
resuscitation in the delivery room. Of these 
35 infants, 33 were born in good condition, 
were subsequently admitted to a NICU/SCBU 
and all survived to discharge. Two infants 
died in the delivery room, one had a diagnosis 
of anencephaly and the other had a life 
threatening birth defect not specifically listed 
by VON. One of these infants was born in a 
regional centre and one in a peripheral centre 
(Figure 4.4). 
A total of 222 (98%) infants born at 27-29 
weeks gestation were admitted to a NICU/
SCBU including 13 (6% of 226 born) infants 
who were subsequently transferred from their 
peripheral birth centres to tertiary centres 
within 48 hours. At 27-29 weeks gestation, 
no infants were transferred from tertiary or 
regional centres. Of the thirteen infants who 
transferred, twelve survived and one died 
(Figure 4.4). 
In all, 208 (92%) infants born at 27-29 weeks 
gestation survived to discharge: 148 (94%) 
of those born in tertiary centres, 48 (92%) of 
those born in regional centres and 12 (75%) 
of those born in peripheral centres (Table 4.6). 
Outcomes of infants born at 27-29 weeks gestation according to 
category of neonatal centre
Survival  Tertiary Regional Peripheral Total
 Centres Centres Centres
Number of liveborn infants 158 52 16 226
No. (%) who received resuscitation in the delivery room 134 (85%) 45 (87%) 12 (75%) 191 (85%)
No. (%) admitted to a NICU/SCBU 156 (99%) 51 (98%) 15 (94%) 222 (98%)
No. (%) transferred to another neonatal centre within  0 (0%) 0 (0%) 13 (81%) 13 (6%)
48 hours of birth
No. survived to discharge  148 48 12 208
% survival to discharge of liveborn infants  94% 92% 75% 92%
Table 4.6: Survival of ROI Infants born at 27-29 weeks gestation by category of neonatal centre, 2015, n=226
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Figure 4.4: Flow chart illustrating survival outcomes of VLBW infants born at 27-29 weeks gestation according to 
designated category of neonatal centre, 2015, n=226
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Overall, there were 223 infants born at >30 
weeks gestation for whom birth location data 
were available. Of these, 133 (60%) were born 
in one of the tertiary neonatal centres, 63 
(28%) in one of the regional neonatal centres 
and 27 (12%) in one of the peripheral centres 
(Table 4.7).  
A total of 142 (64%) infants received 
intensive care/resuscitation in the delivery 
room, including 89 (67%) infants born in 
tertiary centres, 35 (56%) infants born in 
regional centres and 18 (67%) infants born in 
peripheral centres. All survived to admission 
to a NICU/SCBU but four died prior to discharge 
(Figure 4.5). Eighty-one infants did not 
receive resuscitation in the delivery room, of 
whom six died in the delivery room. Of these, 
five had a congenital anomaly. Four of the 
deaths occurred in tertiary centres, one in a 
regional centre and another in a peripheral 
centre. The remaining 75 who did not receive 
resuscitation were admitted to a NICU/SCBU 
and all survived to discharge.
In total, 217 (97%) infants born at >30 weeks 
gestation were admitted to a NICU/SCBU, of 
which twelve were transferred to another 
neonatal centre within 48 hours, including 
two born at tertiary centres, one born at a 
regional centre and nine born at peripheral 
centres (Table 4.7 and Figure 4.5). Eleven 
of these infants survived to discharge. The 
one infant who died was born in a peripheral 
centre. 
In all, 213 (96%) infants born at >30 weeks 
gestation survived to discharge: 126 (95%) 
of those born in tertiary centres, 62 (98%) of 
those born in regional centres and 25 (93%) 
of those born in peripheral centres (Table 4.7). 
Outcomes of infants born at greater than 30 weeks gestation according 
to category of neonatal centre
Survival  Tertiary Regional Peripheral Total
 Centres Centres Centres
Number of liveborn infants 133 63 27 223
No. (%) who received resuscitation in the delivery room 89 (67%) 35 (56%) 18 (67%) 142 (64%)
No. (%) admitted to  a NICU/SCBU 129 (97%) 62 (98%) 26 (96%) 217 (97%)
No. (%) transferred to another neonatal centre  2 (2%) 1 (2%) 9 (33%) 12 (5%)
within 48 hours of birth
No. survived to discharge  126 62 25 213
% survival to discharge of liveborn infants  95% 98% 93% 96%
Table 4.7: Survival of ROI Infants born at >30 weeks gestation by category of neonatal centre, 2015, n=223
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Figure 4.5: Flow chart illustrating survival outcomes of VLBW infants born > 30 weeks gestation according to category 
of neonatal centre, 2015, n=223 
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The three categories of neonatal centre had 
similar survival outcomes in terms of the <24 
weeks and >30 weeks gestational age groups: 
17%, 20% and 21% for tertiary, regional and 
peripheral centres respectively for <24 weeks 
gestation; and 95%, 98% and 93% for tertiary, 
regional and peripheral centres respectively 
for >30 weeks gestation (Table 4.8). With 
regards to the 24-26 weeks and 27-29 weeks 
gestational age ranges, tertiary and regional 
centres had similar rates, but the collective 
of peripheral centres had lower survival rates. 
However, these rates are based on numbers 
that are too small (numerators of 3, 5, 12 and 
25 and denominators of 14, 13, 16 and 27) for 
conclusions to be drawn.
Summary survival outcomes of infants according to category  
sof neonatal centre
 Survival
Gestational Tertiary Regional Peripheral ROI VON  
Age Group Centres  Centres  Centres Total Total
Table 4.8: Survival rates for gestational age categories of VLBW infants born in the ROI according 
to category of neonatal centre, 2015, n=608
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VON reports on a number of Key Performance 
Indicators (KPIs). This allows the ROI to 
compare its outcomes to VON as a whole. It 
is important for benchmarking performance 
in the ROI in addition to identifying areas 
of strengths and areas where continuous 
improvements could/should be made.  
For each KPI, the number and percentage of 
ROI infants that experienced the outcome 
in 2015 is reported and illustrated in the 
following charts alongside the equivalent 
figures for all infants recorded in the VON 
database. The reporting of the KPIs in 
numbers and percentages for ROI and VON 
infants is provided for descriptive purposes. 
Observed differences in KPIs may be related 
to the medical care provided but may also 
be due to differences between the ROI and 
VON infant populations. Robust comparison 
of KPIs between the ROI and VON requires 
that pertinent differences between the infant 
populations are taken into account. This is 
done through the calculation of standardised 
mortality/morbidity ratios (SMRs).
The KPIs are listed below and relevant definitions are outlined above in the Definitions and 
Terminology section:
1. Mortality
2. Mortality Excluding Early Deaths 
3. Death or Morbidity 
4. CLD
5. Pneumothorax
6. Late Bacterial Infection
7. Coagulase Negative Infection
8. Nosocomial Infection
9. Fungal Infection







5. Key Performance Indicators
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Based on all VON data for infants with birth 
weights 501-1500g, our VON colleagues use 
multivariable logistic regression models for 
each KPI to quantify the risk of the outcome 
associated with each of the following infant 
characteristics: gestational age, SGA, multiple 
gestation, Apgar score at 1 min, gender, 
vaginal birth, location (inborn or outborn) and 
birth defect severity. Coefficients from these 
regression models were provided to the NPEC 
for use in the calculation of SMRs for each KPI.
SMRs were calculated for ROI babies with 
birth weights 501-1500g and with complete 
data for the KPI in question and the infant 
characteristics used in the regression models.
For each KPI, the coefficients were applied 
to the data of these eligible ROI infants to 
estimate the risk of the outcome for each 
infant. Summing these individual risk 
estimates gives the total number of infants 
that would be expected to experience the 
outcome, i.e. the expected number taking into 
account the risk profile of the ROI infants.
To obtain the SMR for each KPI, the number of 
eligible ROI infants that actually experienced 
the outcome, i.e. the observed number of 
cases, was divided by the expected number 
of cases (SMR = Observed/Expected).
SMR values equal or close to one indicate that 
there is little or no difference between the 
observed and expected number of infants 
that experienced the outcome, i.e. the number 
observed was to be expected given the risk 
profile of the ROI infant population. SMRs 
greater than one indicate that more infants 
experienced the outcome than expected 
given the risk profile of the ROI infants. SMRs 
less than one indicate that fewer cases were 
observed among ROI infants than expected.
A 95% confidence interval was calculated 
for each SMR in order to facilitate making 
inferences about whether the SMRs indicated 
if the difference between observed and 
expected was statistically significant. If 
the 95% confidence interval did not include 
the value one, it may be inferred that the 
difference between the numbers of observed 
and expected cases was statistically 
significant, i.e. there were more or fewer 
cases among the ROI infants than expected 
given their risk profile.
For each KPI, the absolute difference between 
the observed and expected number of cases 
is reported and the 95% confidence interval 
for this difference is also reported in order 
to provide statements in terms of the actual 
number of infants affected.
Table 5.1 displays Standardised Mortality/
Morbidity Ratios (SMR = Observed/Expected), 
the lower and upper bounds of its 95% 
confidence interval, the difference between 
the Observed and Expected number of cases 
and the lower and upper bound of the 95% 
confidence interval for this difference.`
Standard Mortality/Morbidity Ratios (SMRs)
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Table 5.1: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators, Republic of 
Ireland, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 77 67 1.15 (0.91, 1.39) 10 (-6, 26)
Mortality excluding early death 41 41 1.01 (0.70, 1.31) 0 (-12, 13)
Death or Morbidity 256 221 1.16 (1.03, 1.29) 35 (6, 64)
Chronic Lung Disease 104 97 1.07 (0.87, 1.27) 7 (-13, 26)
Pneumothorax 37 21 1.80 (1.37, 2.24) 16 (8, 25)
Late Bacterial Infection 45 46 0.97 (0.68, 1.26) -1 (-15, 12)
Coagulase Negative Infection 41 26 1.60 (1.22, 1.99) 15 (6, 25)
Nosocomial Infection 80 56 1.43 (1.17, 1.69) 24 (10, 39)
Fungal Infection 3 4 0.70 (0, 1.65) -1 (-5, 3)
Any Late Infection 83 58 1.44 (1.18, 1.70) 25 (10, 40)
Intraventricular Haemorrhage 131 106 1.24 (1.05, 1.43) 25 (5, 46)
Severe Intraventricular Haemorrhage 36 31 1.15 (0.8, 1.51) 5 (-6, 16)
Retinopathy of Prematurity 81 114 0.71 (0.53, 0.89) -33 (-54, -12)
Severe Retinopathy of Prematurity 22 20 1.10 (0.66, 1.54) 2 (-7, 11)
Cystic Periventricular Leukomalacia 16 13 1.26 (0.71, 1.82) 3 (-4, 10)
Necrotising Enterocolitis 37 25 1.47 (1.08, 1.86) 12 (2, 22)
O is the number of observed cases with the outcome and E is the expected number with the outcome of ROI infants with birth weights 501-1500g. 95% 
confidence intervals (CIs) are provided for the SMR and the difference in observed and expected cases.
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Table 5.2: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators, Republic of Ireland, 
2014 and 2015, and the relative risk in 2015 compared to 2014
  2014   2015 
Outcome SMR  (95% CI) SMR  (95% CI) RR (95% CI) 
Mortality 1.27  (1.03, 1.51) 1.15  (0.91, 1.39) 0.90 (0.66, 1.24)
Mortality excluding early death 1.23  (0.92, 1.54) 1.01  (0.70, 1.31) 0.82 (0.53, 1.26)
Death or Morbidity 1.14  (1.01, 1.27) 1.16  (1.03, 1.29) 1.01 (0.85, 1.21)
Chronic Lung Disease 1.08  (0.88, 1.28) 1.07  (0.87, 1.27) 0.99 (0.75, 1.31)
Pneumothorax 1.67  (1.25, 2.10) 1.80  (1.37, 2.24) 1.08 (0.66, 1.76)
Late Bacterial Infection 0.90  (0.58, 1.22) 0.97  (0.68, 1.26) 1.08 (0.68, 1.74)
Coagulase Negative Infection 1.84  (1.45, 2.23) 1.60  (1.22, 1.99) 0.87 (0.56, 1.36)
Nosocomial Infection 1.30  (1.04, 1.57) 1.43  (1.17, 1.69) 1.10 (0.79, 1.54)
Fungal Infection 0.55  (0, 1.57) 0.70  (0, 1.65) 1.28 (0.15, 15.35)
Any Late Infection 1.26  (1.00, 1.52) 1.44  (1.18, 1.7) 1.14 (0.82, 1.59)
Intraventricular Haemorrhage 1.07  (0.88, 1.26) 1.24  (1.05, 1.43) 1.16 (0.90, 1.51)
Severe Intraventricular Haemorrhage 1.22  (0.85, 1.58) 1.15  (0.80, 1.51) 0.95 (0.58, 1.55)
Retinopathy of Prematurity 0.51  (0.33, 0.70) 0.71  (0.53, 0.89) 1.39 (0.98, 1.98)
Severe Retinopathy of Prematurity 0.83  (0.37, 1.29) 1.10  (0.66, 1.54) 1.33 (0.66, 2.76)
Cystic Periventricular Leukomalacia 0.32  (0, 0.87) 1.26  (0.71, 1.82) 3.97 (1.28, 16.33)
Necrotising Enterocolitis 1.21  (0.84, 1.59) 1.47  (1.08, 1.86) 1.22 (0.74, 2.01)
Note: RR = relative risk in 2015 compared to 2014; increase in risk if RR>1; decrease if RR<1; statistically significant if 95% CI does not include the value 1.
The year 2014 was the first year that SMRs for 
each KPI were calculated for ROI infants with 
birth weights 501-1500g, thereby allowing 
an assessment of whether the risk of a KPI 
changed from 2014 to 2015. This was done 
by comparing the SMRs calculated for 2015 to 
those calculated for 2014 using the methods 
described by Breslow and Day (1987) (6). For 
each KPI, this involved calculating the relative 
risk by dividing the SMR for 2015 by the SMR 
for 2014 (RR=SMR 2015 / SMR 2014).
A 95% confidence interval was calculated for 
each relative risk in order to facilitate making 
inferences about whether the change in 
the risk of the KPI from 2014 to 2015 was 
statistically significant. If the 95% confidence 
interval did not include the value one, it may 
be inferred that the change in the risk of 
the KPI from 2014 to 2015 was statistically 
significant, i.e. the risk of the KPI among the 
ROI infants was higher or lower in 2015 than it 
was in 2014.
This approach has the advantage of adjusting 
for the risk profile of the ROI infants in each 
year and any change in this risk profile from 
one year to the next.
For each KPI, Table 5.2 displays the SMR and 
its 95% confidence interval for 2014 and 2015 
and the relative risk comparing the two years 
and its 95% confidence interval.
Relative Risks (RRs)







KPI 1: Mortality and KPI 2: Mortality Excluding Early Death 
In 2015, 16% (n=97) of VLBW babies born in the ROI died, one percentage higher than the 
proportion of VON infants who died (15%, n=9,079). Over half of these ROI infants died either 
within the first 12 hours of life (7%, n=44) or within 12 hours of admission to the NICU (2%, 
n=10; Figure 5.1). After excluding these early deaths, a further 7% (n=43) of ROI infants died. 
When early deaths are excluded, 10% (n=6,046) of VON VLBW infants died.  
 
Figure 5.1: Distribution of mortality amongst ROI and VON infants, 2015. 
 
Deaths in the Delivery Room 2015 
In 2015, a significantly higher proportion of ROI infants died in the delivery room (7%, n=44) 
compared to VON (4%, n=2,304; p<0.001). A similar statistically significant finding was 
obtained in 2014 when 8% (n=50) of ROI infants died in the delivery room compared to 4% 
(n=2,200) in VON. The reduction in ROI delivery room deaths from 8% in 2014 to 7% in 2015 
was not statistically significant (p=0.39).  
Eleven of the 44 (25%) ROI infants who died in the delivery room in 2015 had a major 
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Figure 5.1: Distribution of mortality amongst ROI and VON infants, 2015..
In 2015, 16% (n=97) of VLBW babies born 
in the ROI died, one percentag  higher than 
the proportion of VON infants who died (15%, 
n=9,079). Over h lf of th se ROI infants died 
either within the first 12 hours of life (7%, 
n=44) or within 12 hours of admission to the 
NICU ( %, n=10; Figure 5.1). After excluding 
the e early deaths, a further 7% (n=43) of ROI 
in ants died. When early eaths are excluded, 
10% (n=6,046) of VON VLBW infants died. 
Deaths in the Delivery Room 2015
In 2015, a significantly higher proportion of ROI 
infants died in the delivery room (7%, n=44) 
compared to VON (4%, n=2,304; p<0.001). A 
similar statistically significant finding was 
obtained in 2014 when 8% (n=50) of ROI 
infants died in the delivery room compared 
to 4% (n=2,200) in VON. The reduction in 
ROI delivery room deaths from 8% in 2014 to 
7% in 2015 was not statistically significant 
(p=0.39). 
Eleven of the 44 (25%) ROI infants who died 
in the delivery room in 2015 had a major 
congenital anomaly and a further 28 (64%) 
were born at less than 24 weeks gestation 
(Table 5.3): the analogous figures for 2014 
were 14% (n=7) having major congenital 
anomalies and 72% (n=36) born at less than 
24 weeks gestation. In total, 39 of 44 infants 
(89%) who died in the delivery room in the ROI 
in 2015 had either a major congenital anomaly 
or were less than 24 weeks gestation. This 
was similar to the figure of 86% (43 out of 
50) in 2014. Of note, as in 2014, none of the 
infants less than 24 weeks gestation who died 
in the delivery room had a major congenital 
anomaly. Rather, three infants in each of the 
24-26 weeks, 27-29 weeks and 30-32 weeks 
gestational age categories, as well as two 
infants from the >32 weeks gestational age 
category, who died in the delivery room, were 
born with major congenital anomalies (Table 
5.3).
KPI 1: Mortality and KPI 2: Mortality Excluding Early Death
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 Gestational  Major Congenital Anomaly
 Age Category Present Absent Total 
 < 24 weeks 0 28 28
 24-26 weeks 3 3 6
 27-29 weeks 3 1 4
 30-32 weeks 3 0 3
 > 32 weeks 2 1 3
 Total 11 33 44
Table 5.3 Deaths in the delivery room, by gestational age category and presence of major 
congenital anomaly, 2015, n=44
Figure 5.2 illustrates the change in the 
number of cases of mortality across 
gestational age categories. As gestational 
age increases, there was a clear statistically 
significant decrease in mortality in ROI infants 
(p<0.001). Similarly, there was a statistically 
significant decrease in mortality excluding 
early deaths amongst ROI infants (p<0.001) 
(Figure 5.3). 
Amongst ROI infants with birth weights 501-
1500g, there were 77 deaths observed 
whereas the expected number based on the 
risk profile of the infants in the ROI population 
was 67 (Table 5.4). The SMR was 1.15 (95% 
CI: 0.91, 1.39), indicating that the number of 
observed cases was 1.15 times the expected 
number. In absolute numbers there were 10 
more deaths than expected. This was not a 
statistically significant excess in mortality 
(95% CI: -6, 26).
Excluding early deaths, there were 41 
observed deaths which was identical to the 
expected number (Table 5.4; SMR=1.01, 95% 
CI: 0.70, 1.31). Thus, there was no difference 
in the observed and expected numbers of 
deaths excluding early death.
The relative risk for mortality, at 0.90, 
indicated that the risk was lower in 2015 than 
in 2014 but this reduction was not statistically 
significant (95% CI: 0.66, 1.24; Table 5.2). 
The relative risk for mortality excluding early 
death, at 0.82, also indicated that the risk 
was lower in 2015 than in 2014 but again the 
difference was not statistically significant 
(95% CI: 0.53, 1.26; Table 5.2).
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Figure 5.3: Distribution of mortality excluding early deaths amongst infants by gestational age, 2015 
 
 
Table 5.4: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 1: 
mortality and KPI 2: mortality excluding early death, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 77 67 1.15 (0.91, 1.39) 10 (-6, 26) 
Mortality excluding 
early death 41 41 1.01 (0.70, 1.31) 0 (-12, 13) 
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval 
 
KPI 3: Death or Morbidity 
The KPI, death or morbidity, indicates if an infant died or was known to have one or more of 
the key morbidities of severe IVH, CLD in infants <33 weeks, NEC, pneumothorax, any late 
infection or cystic PVL. In 2015, 46% of ROI infants (n=285) suffered death or morbidity. This 
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Figure 5.2: Distribution of mortality a t i fants by gestation l age, 2015
Figure 5.3: Distribution of mortality excludi  ths amongst infants by gestational age, 2015
Table 5.4: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 1: mortality and KPI 2: 
mortality excluding early death, ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 77 67 1.15 (0.91, 1.39) 10 (-6, 26)
Mortality excluding early death 41 41 1.01 (0.70, 1.31) 0 (-12, 13)
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval
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The KPI, death or morbidity, indicates if 
an infant died or was known to have one 
or more of the key morbidities of severe 
IVH, CLD in infants <33 weeks, NEC, 
pneumothorax, any late infection or cystic 
PVL. In 2015, 46% of ROI infants (n=285) 
suffered death or morbidity. This compares 
to 44% (n=26,865) of VON infants. 
Figure 5.4 illustrates the change in the 
number of cases of death or morbidity across 
gestational age categories. As gestational 
age increases, there was a clear statistically 
significant decrease in death or morbidity in 
ROI infants (p<0.001). 
Amongst ROI infants with birth weights 501-
1500g, there were 256 observed cases of 
death or morbidity, whereas the expected 
number based on the risk profile of the 
infants in the Irish population was 221 (Table 
5.5). The SMR was 1.16 (95% CI: 1.03, 1.29), 
indicating that the number of observed cases 
was 1.16 times the expected number. In 
absolute numbers there were 35 more cases 
of death or morbidity in the ROI than expected, 
a statistically significant excess in death or 
morbidity (95% CI: 6, 64).
The relative risk for death or morbidity, at 1.01, 
indicated that the risk in 2015 was almost 
identical to that in 2014 (Table 5.2). Therefore, 
there was a statistically significant excess 
risk of death or morbidity for ROI infants of a 
similar magnitude in both years (SMR=1.14 in 
2014 vs. 1.16 in 2015; Table 5.2).






Figure 5.4 illustrates the change in the number of cases of death or morbidity across 
gestational age categories. As gestational age increases, there was a clear statistically 
significant decrease in death or morbidity in ROI infants (p<0.001).  
Amongst ROI infants with birth weights 501-1500g, there were 256 observed cases of death 
or morbidity, whereas the expected number based on the risk profile of the infants in the Irish 
population was 221 (Table 5.5). The SMR was 1.16 (95% CI: 1.03, 1.29), indicating that the 
number of observed cases was 1.16 times the expected number. In absolute numbers there 
were 35 more cases of death or morbidity in the ROI than expected, a statistically significant 
excess in death or morbidity (95% CI: 6, 64). 
The relativ  risk for death or morbidity, at 1.01, i i  t at the risk in 2015 was almost 
identical to that in 2014 (T ble 5.2). Therefore, there was a statistically significant excess risk 
of de th or morbidity for ROI infants of a similar magnitude in both years (SMR=1.14 in 2014 
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Figure 5.4: Distribution of death or morbidity amongst infants by gestational age, 2015
Table 5.5: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 3: death or morbidity, ROI, 
2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Death or Morbidity 256 221 1.16 (1.03, 1.29) 35 (6, 64)
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval
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In 2015, 21% of ROI infants (n=109) were 
classified as having CLD. This compares to 
24% of VON infants (n=12,500). 
Figure 5.5 illustrates the change in CLD 
cases across all gestational age categories. 
As gestational age increases, there was a 
significant decrease in CLD cases amongst 
ROI infants (p<0.001). 
There were 104 observed cases of CLD 
amongst ROI infants with birth weights 501-
1500g whereas the expected number based 
on the risk profile of infants in the Irish 
population was 97 (Table 5.6). The SMR was 
1.07 (95% CI: 0.87, 1.27), indicating that the 
number of observed cases was 1.07 times 
the expected number. In absolute numbers 
there were seven more cases of CLD than 
expected: this was not a statistically 
significant excess (95% CI:-13, 26).
The relative risk for CLD, at 0.99, indicated 
that the risk in 2015 was almost identical to 
that in 2014 (Table 5.2). There was a risk of 
CLD of similar magnitude in both years, but 
this risk was not statistically significant in 
either year (SMR=1.08 in 2014 vs. 1.07 in 
2015; Table 5.2).







Figure 5.5: Distribution of chronic lung disease amongst infants by gestational age, 2015 
   
Table 5.6: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 4: 
chronic lung disease, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Chronic Lung Disease 104 97 1.07 (0.87, 1.27) 7 (-13, 26) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 5: Pneumothorax  
In 2015, 7% of ROI infants (n=40) were classified as having pneumothorax. This compares to 
4% (n=2,637) of VON infants.   
Figure 5.6 outlines the proportion of pneumothorax in ROI and VON infants according to 
gestational age categories. In ROI infants, increasing gestational age was associated with a 
slight decrease in cases of pneumothorax but this decrease was not statistically significant 
(p=0.281). It must be noted that the number of pneumothorax cases seen across gestational 
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Figure 5.5: Distri i   r ic lung disease amongst i fants by gest tional age, 2015
Table 5.6: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 4: chronic lung disease, 
ROI, 2015
 O E SMR (95% CI) O-E (95% CI) 
Chronic Lung Disease 104 97 1.07 (0.87, 1.27) 7 (-13, 26)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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In 2015, 7% of ROI infants (n=40) were 
classified as having pneumothorax. This 
compares to 4% (n=2,637) of VON infants. 
 
Figure 5.6 outlines the proportion of 
pneumothorax in ROI and VON infants 
according to gestational age categories. In 
ROI infants, increasing gestational age was 
associated with a slight decrease in cases 
of pneumothorax but this decrease was not 
statistically significant (p=0.281). It must 
be noted that the number of pneumothorax 
cases seen across gestational age 
categories in ROI infants was quite small.
There were 37 observed cases of 
pneumothorax amongst ROI infants with 
birth weights 501-1500g whereas the 
expected number based on the risk profile 
of the infants in the Irish population was 
21 (Table 5.7). The SMR was 1.80 (95% CI: 
1.37, 2.24), indicating that the number of 
observed cases was 1.80 times the expected 
number. This was a statistically significant 
excess of 16 cases of pneumothorax (95% 
CI: 8, 25).  
The relative risk for pneumothorax, at 1.08, 
indicated that the risk was higher in 2015 
than in 2014, but this increase was not 
statistically significant (95% CI: 0.66, 1.76; 
Table 5.2). 






There were 37 observed cases of pneumoth rax amongst ROI infants with birth weig ts 501-
1500g whereas the expected number based on the risk profile of the infants in the Irish 
population was 21 (Ta l  5.7). The SMR w s 1.80 (95% CI: 1.37, 2.24), indicating that the 
number of observed cases was 1.80 times the expected number. This was a statistically 
significant excess of 16 cases of pneumothorax (95% CI: 8, 25).   
The relative risk for pneumothorax, at 1.08, indicated that the risk was higher in 2015 than in 
2014, but this increase was not statistically significant (95% CI: 0.66, 1.76; Table 5.2).  
 
Figure 5.6: Distribution of pneumothorax amongst infants by gestational age, 2015  
 
Table 5.7: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 5: 
pneumothorax, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Pneumothorax 37 21 1.80 (1.37, 2.24) 16 (8, 25) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
















< 24 weeks 24-26 weeks 27-29 weeks 30-32 weeks > 32 weeks
Republic of Ireland VON
Figure 5.6: Distribution of pneumothorax amongst infants by gestational age, 2015 
Table 5.7: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 5: pneumothorax, 
ROI, 2015
 O E SMR (95% CI) O-E (95% CI) 
Pneumothorax 37 21 1.80 (1.37, 2.24) 16 (8, 25)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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Figure 5.7 compares the proportion of 
infections in ROI and VON infants. There was 
no significant difference in rates of any 
infection between the two populations (late 
bacterial infection: p=0.522; coagulase 
negative infection: p=0.092; nosocomial 
infection: p=0.194; fungal infection: 
p=0.363; any late infection: p=0.094). The 
slightly lower percentage of late bacterial 
infection and slightly higher percentages of 
coagulase negative infection, nosocomial 
infection and any late infection seen in ROI 
infants reflects the pattern observed in 
2014 (7). 
The proportion of late bacterial infection 
in ROI infants was 8% (n=46) compared to 
9% (n=4,933) in all VON infants. Figure 5.8 
illustrates the prevalence of late bacterial 
infection across all gestational age 
categories. As gestational age increases, 
there was a statistically significant 
decrease in cases of late bacterial infection 
in ROI infants (p<0.001). 
Amongst ROI infants with birth weights 
501-1500g, there were 45 observed cases 
of late bacterial infection compared to an 
expected number of 46 cases (Table 5.8). 
Thus, the observed number was 0.97 times 
the expected number (SMR=0.97, 95% CI: 
0.68, 1.26). In absolute numbers there 
was one less case of late bacterial infection 
than expected, which was not statistically 
significant (95% CI: -15, 12).
The relative risk for late bacterial infection, 
at 1.08, indicated that the risk was slightly 
higher in 2015 than in 2014, but this 
increase was not statistically significant 
(95% CI: 0.68, 1.74; Table 5.2). 
KPIs 6 – 10: Infections: late bacterial infection, coagulase negative 
infection, nosocomial infection, fungal infection and any late infection. 
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Figure 5.7: Distribution of infections in ROI and VON infants, 2015 
 
KPI 6: Late Bacterial Infection 
The proportion of  bacterial infection i ROI infants was 8% (n=46) compared to 9% 
(n=4,933) in all VON infants. Figure 5.8 illustrates the pr valence of late bacteri l infection 
across all gestational age categories. As gestational age increases, there was a statistically 
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Figure 5.7: Distribution of infections in ROI and VON infants, 2015
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Amongst ROI infants with birth weights 501-1500g, there were 45 observed cases of late 
bacterial infection compared to an expected number of 46 cases (Table 5.8). Thus, the 
observed number was 0.97 times the expected number (SMR=0.97, 95% CI: 0.68, 1.26). In 
absolute numbers there was one less case of late bacterial infection than expected, which 
was not statistically significant (95% CI: -15, 12). 
The relative risk for late bacterial infection, at 1.08, indicated that the risk was slightly higher 
in 2015 than in 2014, but this increase was not statistically significant (95% CI: 0.68, 1.74; 
Table 5.2).  
  
Figure 5.8: Distribution of late bacterial infection amongst infants by gestational age, 2015 
 
Table 5.8: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 6: late 
bacterial infection, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Late Bacterial Infection 45 46 0.97 (0.68, 1.26) -1 (-15, 12) 
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Figure 5.8: Distribution of late acterial i fection amongst infants by gestational age, 2015
Table 5.8: Risk Adj t  Standardised Morbidity Ratios for Key Performance Indicators - KPI 6: late bacterial infection, 
ROI, 2015
t  O E SMR (95% CI) O-E (95% CI) 
Late Bacterial Infection 45 46 0.97 (0.68, 1.26) -1 (-15, 12)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Coagulase negative infection was observed 
in 8% (n=43) of ROI infants and 6% of VON 
infants (n=3,385). Figure 5.9 illustrates 
the change in cases of coagulase negative 
infection across all gestational age categories. 
In ROI infants, increasing gestational age was 
associated with a statistically significant 
decrease in cases of coagulase negative 
infection (p<0.001).
Adjusting for the risk profile of ROI infants born 
weighing 501-1500g, there were 41 observed 
cases of coagulase negative infection 
compared to an expected number of 26 cases 
(Table 5.9). Thus, the observed number was 
1.60 times the expected number (SMR=1.60, 
95% CI: 1.22, 1.99). In absolute numbers 
there were 15 more cases of coagulase 
negative infection than expected, which was a 
statistically significant excess (95% CI: 6, 25).
The relative risk for coagulase negative 
infection, at 0.87, indicated that the risk 
was lower in 2015 than in 2014 but this 
reduction was not statistically significant 
(95% CI: 0.56, 1.36; Table 5.2). 
KPI 7: Coagulase Negative Infection 







KPI 7: Coagulase Negative Infection 
Coagulase negative infection was observed in 8% (n=43) of ROI infants and 6% of VON infants 
(n=3,385). Figure 5.9 illustrates the change in cases of coagulase negative infection across all 
gestational age categories. In ROI infants, increasing gestational age was associated with a 
statistically significant decrease in cases of coagulase negative infection (p<0.001). 
Adjusting for the risk profile of ROI infants born weighing 501-1500g, there were 41 observed 
cases of coagulase negative infection compared to an expected number of 26 cases (Table 
5.9). Thus, the observed number was 1.60 times the expected number (SMR=1.60, 95% CI: 
1.22, 1.99). In absolute numbers there were 15 more cases of coagulase negative infection 
than expected, which was a statistically significant excess (95% CI: 6, 25). 
The relative risk for coagulase negative infection, at 0.87, indicated that the risk was lower in 
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Figure 5.9: Distribution of c l e negative infection amongst i fants by gest tional age, 2015
Table 5.9: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 7: coagulase negative 
infection, ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Coagulase Negative Infection 41 26 1.60 (1.22, 1.99) 15 (6, 25)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Nosocomial infection was reported in 
15% (n=83) of the ROI infant population 
and 13% (n=7,227) of the VON population. 
Figure 5.10 illustrates the change in 
cases of nosocomial infection across all 
gestational age categories. As gestational 
age increases, there was a statistically 
significant decrease in cases of nosocomial 
infection in ROI infants (p<0.001).
 
There were 80 observed cases of 
nosocomial infection amongst ROI infants 
with birth weights 501-1500g, whereas 
the expected number based on the risk 
profile of the infants was 56 cases (Table 
5.10). Thus, there were 1.43 times more 
cases observed than expected (SMR=1.43, 
95% CI: 1.17, 1.69). In absolute numbers 
this equated to an excess of 24 cases, a 
statistically significant difference (95% CI: 
10, 39).
At 1.10, the relative risk indicated that the 
risk for nosocomial infection was higher in 
2015 than in 2014, but this increase in risk 
was not statistically significant (95% CI: 
0.79, 1.54; Table 5.2). 
KPI 8: Nosocomial Infection
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Figure 5.10: Distribution of nosocomial infection amongst infants by gestational age, 2015 
 
Table 5.10: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 8: 
nosocomial infection, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Nosocomial Infection 80 56 1.43 (1.17, 1.69) 24 (10, 39) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 9: Fungal Infection 
Three (0.5%) ROI infants experienced fungal infection in 2015, compared to 516 (0.9%) infants 
in VON.  One ROI infant was in the < 24 weeks gestational age category and two in the 27-29 
weeks category. Graphs are not included.  
The three observed cases of fungal infection were amongst the infants born weighing 501-
1500g. Based on the risk profile of ROI infants, there was an expected number of four cases 
(Table 5.11). One less case of fungal infection than expected did not constitute a statistically 
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Figure 5.10: Distribution of nosocomial infection amongst infants by gestational age, 2015
Table 5.10: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 8: nosocomial infection, 
ROI, 2015
Table 5.11: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 9: fungal infection, ROI, 
2015
tc  O E SMR (95% CI) O-E (95% CI) 
Nosocomial Infection 80 56 1.43 (1.17, 1.69) 24 (10, 39)
Outcome O E SMR (95% CI) O-E (95% CI) 
Fungal Infection 3 4 0.70 (0, 1.65) -1 (-5, 3)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Three (0.5%) ROI infants experienced fungal 
infection in 2015, compared to 516 (0.9%) 
infants in VON.  One ROI infant was in the < 
24 weeks gestational age category and two 
in t  27-29 we ks category. Graphs are not 
included. 
The three observed cases of fungal 
infection were amongst the infants born 
weighing 501-1500g. Based on the risk 
profile of ROI infants, there was an expected 
number of four cases (Table 5.11). One less 
case of fungal infection than expected did 
not constitute a statistically significant 
reduction in fungal infection cases (95% CI: 
-5, 3).
Th  relative risk for fungal infection in 2015, 
at 1.28, was greater than the risk in 2014 
but this increase in risk was not statistically 
significant (95% CI: 0.15, 15.35; Table 5.2). 
KPI 9: Fungal Infection
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Any late infection was reported for 15% of 
ROI infants (n=86) and 13% of VON infants 
(n=7,456). Figure 5.11 illustrates the 
change in cases of any late infection across 
gestational age categories. As gestational 
age increases, there was a statistically 
significant decrease in cases of any late 
infection in ROI infants (p<0.001). 
Considering ROI infants born weighing 
501-1500g for whom risk adjustment was 
performed, there were 83 observed cases 
with any late infection compared to an 
expected number of 58 cases (Table 5.12). 
Thus, the observed number equated to 1.44 
times the expected number (SMR=1.44, 
95% CI: 1.18, 1.70) and the excess of 25 
cases was statistically significant (95% CI: 
10, 40).
The relative risk for any late infection in 
2015 was 1.14 times the risk in 2014: this 
difference between the years was not 
statistically significant (95% CI: 0.82, 1.59; 
Table 5.2).  








Figure 5.11: Distribution of any late infection amongst infants by gestational age, 2015 
  
Table 5.12: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 10: any 
late infection, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Any Late Infection 83 58 1.44 (1.18, 1.70) 25 (10, 40) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 11: Any IVH and KPI 12: Severe IVH 
Overall, 27% (n=140) of ROI infants experienced IVH compared to 25% (n=13,330) of VON 
infants. Of these, 7% (n=38) of ROI infants had severe IVH, i.e. Grade 3 or 4, compared to 8% 
(n=4,227) of VON infants. Figures 5.12 and 5.13 illustrate the change in cases of IVH and 
severe IVH respectively across gestational age categories. As gestational age increases, there 
was a statistically significant decrease in cases of both IVH (p<0.001) and severe IVH (p<0.001) 
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Figure 5.11: Distribution of any late infection amongst infants by gestational age, 2015
Table 5.12: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 10: any late infection, 
ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Any Late Infection 83 58 1.44 (1.18, 1.70) 25 (10, 40)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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Overall, 27% (n=140) of ROI infants 
experienced IVH compared to 25% 
(n=13,330) of VON infants. Of these, 7% 
(n=38) of ROI infants had severe IVH, i.e. 
Grade 3 or 4, compared to 8% (n=4,227) of 
VON infants. Figures 5.12 and 5.13 illustrate 
the change in cases of IVH and severe 
IVH respectively across gestational age 
categories. As gestational age increases, 
there was a statistically significant 
decrease in cases of both IVH (p<0.001) 
and severe IVH (p<0.001) in ROI infants. 
IVH was observed in 131 ROI infants weighing 
501-1500g at birth whereas the number of 
cases expected based on the infants’ risk 
profile was 106 (Table 5.13). The observed 
number was statistically significantly 
higher than expected (SMR=1.24, 95% CI: 
1.05, 1.43). In absolute numbers, there 
were 25 more cases than expected, which 
was also statistically significant (95% CI: 5, 
46). The relative risk for IVH in 2015, at 1.16, 
was greater than the risk in 2014, but this 
increase was not statistically significant 
(95% CI: 0.90, 1.51; Table 5.2). 
 
In cases of severe IVH, there were 36 
observed cases compared to an expected 
number of 31 cases (SMR=1.15, 95% CI: 
0.8, 1.51): this excess of five cases was 
not statistically significant (95% CI: -6, 16; 
Table 5.13). The relative risk for severe IVH 
in 2015 was 0.95 times the risk in 2014: 
this reduction in risk was not statistically 
significant (95% CI: 0.58, 1.55; Table 5.2).  






IVH was observed in 131 ROI infants weighing 501-1500g at birth whereas the number of 
cases expected based on the infants’ risk profile was 106 (Table 5.13). The observed number 
was statistically significantly higher than expected (SMR=1.24, 95% CI: 1.05, 1.43). In absolute 
numbers, there were 25 more cases than expected, which was also statistically significant 
(95% CI: 5, 46). The relative risk for IVH in 2015, at 1.16, was greater than the risk in 2014, but 
this increase was not statistically significant (95% CI: 0.90, 1.51; Table 5.2).   
In cases of severe IVH, there were 36 observed cases compared to an expected number of 31 
cases (SMR=1.15, 95% CI: 0.8, 1.51): this excess of five cases was not statistically significant 
(95% CI: -6, 16; T ble 5.13). The relative risk for severe IVH in 2 15 was 0.95 times the risk in 
2014: this reduction in risk was not statistically significant (95% CI: 0.58, 1.55; Table 5.2).   
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Figure 5.12: Distribution of any IVH amongst infants by gestational age, 2015







Figure 5.13: Distribution of severe IVH amongst infants by gestational age, 2015 
 
  
Table 5.13: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 11: 
intraventricular haemorrhage and KPI 12: severe intraventricular haemorrhage, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Intraventricular 
Haemorrhage 131 106 1.24 (1.05, 1.43) 25 (5, 46) 
Severe Intraventricular 
Haemorrhage 36 31 1.15 (0.8, 1.51) 5 (-6, 16) 
O=observed, E-expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 13: ROP and KPI 14: Severe ROP 
ROP was reported in 19% (n=86) of ROI infants and 31% (n=13,679) of VON infants. Severe 
ROP (stage 3, 4 or 5) was reported for 5% (n=24) of ROI infants and 6% (n=2,648) of VON 
infants. Figures 5.14 and 5.15 illustrate the change in cases of ROP and severe ROP 
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Figure 5.13: Distribution of severe IVH amongst infants by gestational age, 2015
Table 5.13: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 11: intraventricular 
haemorrhage and KPI 12: severe intraventricular haemorrhage, ROI, 2015
Outcome O E SM  (95% CI) O-E (95% CI) 
Intraventricular Haemorrhage 131 106 1.24 (1.05, 1.43) 25 (5, 46)
Severe Intraventricular Haemorrhage 36 31 1.15 (0.8, 1.51) 5 (-6, 16)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
ROP was reported in 19% (n=86) of ROI infants 
and 31% (n=13,679) of VON infants. Severe ROP 
(stage 3, 4 or 5) was reported for 5% (n=24) of 
ROI infants and 6% (n=2,648) of VON infants. 
Figures 5.14 and 5.15 illustrate the change in 
cases of ROP and severe ROP respectively across 
gestational age categories. As gestational age 
increases, there was a statistically significant 
decrease in both cases of ROP (p<0.001) and 
cases of severe ROP (p<0.001) in ROI infants.
Considering ROI infants born weighing 
501-1500g for whom risk adjustment was 
performed, there were 81 observed cases of 
ROP compared to an expected number of 114 
cases (Table 5.14). Thus, the observed number 
equated to 71% of the expected number, 
which constituted a statistically significant 
difference (SMR=0.71, 95% CI: 0.53, 0.89). In 
absolute numbers, there were 33 fewer cases 
of ROP than expected, which was a statistically 
significant reduction (95% CI: -54, -12).
The relative risk for ROP, at 1.39, indicated 
that the risk for ROP was higher in 2015 than 
in 2014, but this increase was not statistically 
significant (95% CI: 0.98, 1.98; Table 5.2).
With regard to severe ROP, there were 22 
observed cases compared to 20 cases which 
would be expected based on the risk profile of 
infants in the ROI population (SMR=1.10, 95% CI: 
0.66, 1.54): the difference of two cases between 
the observed and the expected values was not 
statistically significant (95% CI: -7, 11; Table 5.14).
The relative risk, at 1.33, for severe ROP 
indicates that the risk was greater in 2015 than 
in 2014, but this difference was not statistically 
significant (95% CI: 0.66, 2.76; Table 5.2).  
KPI 13: ROP and KPI 14: Severe ROP
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Figure 5.15: Distribution of severe ROP amongst infants by gestational age, 2015 
 
Table 5.14: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 13: 
retinopathy of prematurity and KPI 14: severe retinopathy of prematurity, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Retinopathy of 
Prematurity 81 114 0.71 (0.53, 0.89) -33 (-54, -12) 
Severe Retinopathy of 
Prematurity 22 20 1.10 (0.66, 1.54) 2 (-7, 11) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 15: Cystic PVL 
Similar proportions of cystic PVL were observed in ROI and VON infants in 2015, at 3% (n=17) 
and 3% (n=1,655) respectively. Figure 5.16 illustrates the change in cases of cystic PVL across 
gestational age categories. There was no significant change in number of cases of cystic PVL 
as gestational age (p=0.307) increased and it is noted that the overall number of cystic PVL 
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Figure 5.14: Distribution of ROP amongst infants by gestational age, 2015
Figure 5.15: Distribution of severe ROP amongst infants by gestational age, 2015
Table 5.14: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 13: retinopathy of 
prematurity and KPI 14: severe retinopathy of prematurity, ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Retinopathy of Prematurity 81 114 0.71 (0.53, 0.89) -33 (-54, -12)
Severe Retinopathy of Prematurity 22 20 1.10 (0.66, 1.54) 2 (-7, 11)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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Similar proportions of cystic PVL were 
observed in ROI and VON infants in 2015, at 3% 
(n=17) and 3% (n=1,655) respectively. Figure 
5.16 illustrates the change in cases of cystic 
PVL across gestational age categories. There 
was no significant change in number of cases 
of cystic PVL as gestational age (p=0.307) 
increased and it is noted that the overall 
number of cystic PVL cases observed in ROI 
infants was small.
Considering ROI infants with 501-1500g birth 
weights, there were 16 observed cases of 
cystic PVL whereas the number expected 
based on their risk profile was 13 (Table 5.15). 
Thus, the observed number equated to 1.26 
times the expected number (SMR=1.26, 95% 
CI: 0.71, 1.82). In absolute numbers the three 
more cases observed did not represent a 
statistically significant difference from the 
expected number (95% CI: -4, -10).
At 3.97, the relative risk for cystic PVL in 2015 
was statistically significantly greater than the 
risk in 2014 (95% CI: 1.28, 16.33; Table 5.2). 
However, the small number of cases in both 
years (three in 2014 and 17 in 2015) preclude 
definitive conclusions being drawn.
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Figure 5.16: Distribution of cystic PVL amongst infants by gestational age, 2015 
 
Table 5.15: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 15: 
cystic periventricular leukomalacia, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Cystic Periventricular 
Leukomalacia 
16 13 1.26 (0.71, 1.82) 3 (-4, 10) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
5% 4% 4%
1% 3%
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Figure 5.16: Distribution of cystic PVL amongst infants by gestational age, 2015
Table 5.15: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 15: cystic periventricular 
leukomalacia, ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Cystic Periventricular Leukomalacia 16 13 1.26 (0.71, 1.82) 3 (-4, 10)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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NEC was observed in 7% (n=40) of ROI infants 
and 5% (n=3,056) of VON infants in 2015. 
Figure 5.17 illustrates the change in cases 
of NEC across all gestational age categories. 
As gestational age increases, there was a 
statistically significant decrease in cases of 
NEC in ROI infants (p<0.001). 
Amongst the ROI infants born weighing 501-
1500g there were 37 observed cases of 
NEC and an expected number of 25 cases 
(SMR=1.47, 95% CI: 1.08, 1.86; Table 5.16). 
This was a statistically significant excess of 
12 cases of NEC (95% CI: 2, 22).
The relative risk for NEC, at 1.22, indicated that 
the risk was higher in 2015 than in 2014, but 
this increase was not statistically significant 
(95% CI: 0.74, 2.01; Table 5.2). 






KPI 16: Necrotising Enterocolitis (NEC) 
NEC was observed in 7% (n=40) of ROI infants and 5% (n=3,056) of VON infants in 2015. Figure 
5.17 illustrates the change in cases of NEC across all gestational age categories. As gestational 
age increases, there was a statistically significant decrease in cases of NEC in ROI infants 
(p<0.001).  
Amongst the ROI infants born weighing 501-1500g there were 37 observed cases of NEC and 
an expected number of 25 cases (SMR=1.47, 95% CI: 1.08, 1.86; Table 5.16). This was a 
statistically significant excess of 12 cases of NEC (95% CI: 2, 22). 
The relative risk for NEC, at 1.22, indicated that the risk was higher in 2015 than in 2014, but 
this increase was not statistically significant (95% CI: 0.74, 2.01; Table 5.2).  
Figure 5.17: Distribution of NEC amongst infants by gestational age, 2015.   
Table 5.16: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 16: 
necrotising enterocolitis, ROI, 2015 
Outcome O E SMR (95% CI) O-E (95% CI) 
Necrotising 
Enterocolitis 
37 25 1.47 (1.08, 1.86) 12 (2, 22) 
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Figure 5.17: Distribution of NEC a t i fants by ges ation l age, 2015.  
Table 5.16: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 16: necrotising 
enterocolitis, ROI, 2015
Outcome O E SMR (95% CI) O-E (95% CI) 
Necrotising Enterocolitis 37 25 1.47 (1.08, 1.86) 12 (2, 22)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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National Office of Clinical Audit, 2nd Floor, Ardilaun House, 111 St Stephen’s Green, Dublin 2   Tel: + (353) 1 4028577               
 
 
Dr. Brendan Paul Murphy  
Consultant Neonatologist  
Cork University Maternity Hospital  
Wilton  
Cork  
11th April 2017 
 
 
Very Low Birth Weight Infants in the Republic of Ireland - Annual Report 2015 
 
Dear Dr Murphy,  
 
On behalf of the NOCA Governance Board and our Executive Team, I wish to congratulate you, Dr 
Anne Twomey, the Neonatal Intensive Care Outcomes Research and Evaluation (NICORE) group and 
the National Perinatal Epidemiology Centre (NPEC) and all participating neonatal units for your 
combined efforts in initiating and supporting this valuable quality improvement initiative.  
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
Please accept this as formal endorsement from the NOCA Governance Board of the Very Low Birth 
Weight Infants in the Republic of Ireland - Annual Report 2015 
 








Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
 
c.c. Dr. Anne Twomey, National Maternity Hospital, Holles Street, Dublin 2, Ireland  
Prof Richard Greene, National Perinatal Epidemiology Centre, CUMH, Cork 
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Appendix B: NICORE Group Members, 2015
Dr Muhammad Azam, Consultant Paediatrician, Wexford General Hospital
Dr Paula Cahill, Consultant Paediatrician, Portiuncula Hospital
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital
Dr Animitra Das, Consultant Neonatologist, University Hospital Waterford
Dr Anne Doolan, Consultant Paediatrician, University Maternity Hospital Limerick  
(From 2016, Coombe Women & Infants University Hospital)
Dr Alan Finan, Consultant Paediatrician, Cavan General Hospital
Dr Emma Gordon, Consultant Neonatologist, Our Lady of Lourdes Hospital
Dr Rizwan Gul, Consultant Paediatrician, Midland Regional Hospital Portlaoise
Dr Rizwan Khan, Consultant Paediatrician, University Hospital Kerry  
(From 2017, University Maternity Hospital Limerick)
Dr Imelda Lambert, Consultant Paediatrician, Midland Regional Hospital, Mullingar
Dr Jan Miletin, Consultant Neonatologist, Coombe Women & Infants University Hospital
Dr Brendan Paul Murphy, Consultant Neonatologist, Cork University Maternity Hospital
Dr Donough O’Donovan, Consultant Neonatologist, University Hospital Galway
Dr Justin Roche, Consultant Paediatrician, South Tipperary General Hospital
Dr Hilary Stokes, Consultant Paediatrician, Mayo University Hospital
Dr Mathew Thomas, Consultant Paediatrician, Letterkenny University Hospital
Dr Hilary Greaney, Consultant Paediatrician, Sligo University Hospital
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital
Dr David Waldron, Consultant Paediatrician, St. Luke’s General Hospital
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Appendix C: Vermont Oxford Network Data Collection 
Forms 
Rel 19.0  Copyright  ©2014 Vermont Oxford Network, Inc.   All Rights Reserved. 
VERMONT OXFORD NETWORK  
PATIENT DATA BOOKLET FOR INFANTS BORN IN 2015 
Contents:
Page 1: Patient Identification Worksheet 
Page 2: Length of Stay Calculation Worksheet 
Page 3: 28 Day Form 
Pages 4 & 5:  Discharge Form (2 pages)
Page 6:  Transfer and Readmission Form (only infants who transfer to another hospital)
Page 7:  Supplemental Data Form (Expanded Database only)
W1. Patient’s Name: _________________________________________
W2. Mother’s Name: _________________________________________
W3. Patient’s Medical Record Number: ________________________________
W4. Date of Birth:   _____/_____/_____
MM         DD      YYYY
W5. Date of Admission:  _____/_____/_____ For inborn infants, the date of admission is the Date of Birth.
MM          DD       YYYY For outborn infants, the date of admission is the date the infant was 
admitted to your hospital.
W6. Date of Day 28:  ____/____/____
MM      DD     YYYY 
W7. Date of Week 36:  ____/____/____
MM      DD     YYYY 
W8. Date of Initial Disposition:  _____/_____/_____ 
MM           DD        YYYY 
W9. If Infant Transferred, Date Discharged Home, Died or First Birthday (if still hospitalized),
whichever is soonest: _____/_____/_____ 
MM DD YYYY 
DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information
PATIENT IDENTIFICATION WORKSHEET
The Patient Identification Worksheet contains personal patient identifiers and must 
NOT be submitted to the Vermont Oxford Network. The Vermont Oxford Network 




Use the Calculation Charts for Date of Day 28 and Date of Week 36 
for the infant’s birth year.
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 Rel 19.0  Copyright ©2014 Vermont Oxford Network, Inc. All Rights Reserved. 2
LENGTH OF STAY CALCULATION WORKSHEET 
FOR INFANTS BORN IN 2015 
Protected Health Care Information. DO NOT SUBMIT this Worksheet to Vermont Oxford Network. 
Use items W5, W8 and W9 from the Patient Identification Worksheet when completing this form. 
Find the day numbers corresponding to dates using the Day Number Chart for 2015-2016 (www.vtoxford.org). 
PLEASE DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information 
Part A. Initial Length Of Stay
Enter Date of Initial Discharge, Transfer or Death (W8):  ____/____/____ Day #
Subtract Date of Admission to Your Hospital (W5):         ____/____/____     ▬  Day #
Add 1: + 1
L1. INITIAL LENGTH OF STAY = Days  
Note: the maximum value of Initial Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
Part B. Total Length Of Stay
Only For Infants Transferred From Your Hospital to Another Hospital.
Enter Date of Final Discharge or Death (W9): ____/____/____ Day #
Subtract  Date of Admission (W5): ____/____/____ ▬  Day # 
Add 1: + 1
L2. TOTAL LENGTH OF STAY = Days
Note: the maximum value of Total Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
SAMPLE CALCULATION OF INITIAL LENGTH OF STAY 
Enter Date of Initial Discharge, Transfer or Death:  02 / 26 / 2015
Subtract Date of Admission:                                  01 / 13 / 2015 ▬ 
Add 1: +
L1. INITIAL LENGTH OF STAY =          Days
Explanation: Date of 02/26/2015 is Day Number 57.  Date of 01/13/2015 is Day Number 13.  The day numbers for each 
date are found in the 2015-2016 Day Number Chart on the Network web site, www.vtoxford.org.
5 7 Day #




Network ID Number:  Center Number:________
For inborn infants, the date of admission is the Date of Birth.
For outborn infants, the date of admission is the date the infant was admitted to your hospital.
For inborn infants, the date of admission is the Date of Birth.
For outborn infants, the date of admission is the date the infant was admitted to your hospital.
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 Rel 19.0 © 2014 Vermont Oxford Network, Inc.  All Rights Reserved. 06/10/2014
28 DAY FORM - For Infants Born in 2015
Center Number: ________   Network ID Number:   Year of Birth:  ______ 
1. Birth Weight:  ________ grams 
2. Gestational Age: a) Weeks _______ b) Days (0-6) _______
3. Died in Delivery Room:  Yes No (If Yes, Use Delivery Room Death Form.) 
4.   a) Location of Birth: Inborn  Outborn
b) If Outborn, Day of Admission to Your Center (Range: 1 to 28.  Date of Birth is Day 1):  _______
c) If Outborn, Transfer Code of Center from which Infant Transferred: __________
(List available at http://www.vtoxford.org/transfers)
5. Head Circumference at Birth (in cm to nearest 10th):
6. Maternal Ethnicity/Race (Answer both a and b):
a) Ethnicity of Mother:  Hispanic  Not Hispanic 
b) Race of Mother:  Black or African American   White  Asian
 American Indian or Alaska Native  Native Hawaiian or Other Pacific Islander 
 Other 
7. Prenatal Care: Yes No
8. Antenatal Steroids:  Yes  No 
9. Antenatal Magnesium Sulfate:  Yes  No 
10. Chorioamnionitis:  Yes No
11. Maternal Hypertension, Chronic or Pregnancy-Induced:  Yes No
12. Mode of Delivery:  VaginaI  Cesarean Section 
13. Sex of Infant:  Male  Female 
14. a) Multiple Gestation:  Yes No b) If Yes, Number of Infants Delivered:  _____
15. APGAR Scores: a) 1 minute _______  b) 5 minutes _______
16. Initial Resuscitation:  a) Oxygen:  Yes No
b) Face Mask Vent:  Yes No
c) Endotracheal Tube Vent:  Yes No
d) Epinephrine:  Yes No
e) Cardiac Compression:  Yes No
f) Nasal CPAP  Yes No
17.  a) Temperature Measured within the First Hour after Admission to Your NICU: 
 Yes       No             N/A 
b) If Yes, Temperature Within the  First Hour after Admission to Your NICU
(in degrees centigrade to nearest 10th):
18. Bacterial Sepsis on or before Day 3:  Yes No
19. Oxygen on Day 28:  Yes No  N/A (See Manual for N/A criteria) 
20. Periventricular-lntraventricular Hemorrhage (PIH):
a) Cranial Imaging (US/CT/MRI) on or before Day 28: Yes No 
b) If Yes, Worst Grade of PIH (0-4):  _______ 
c) If PIH Grade 1-4, Where PIH First Occurred:  Your Hospital  Other Hospital  N/A
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37. Respiratory Distress Syndrome:  Yes No
 38. a) Pneumothorax:  Yes    No
b) If Yes, Where Occurred:  Your Hospital  Other Hospital  Both 
39. Patent Ductus Arteriosus:  Yes No
40. a) Necrotizing Enterocolitis:  Yes    No
b) If Yes, Where Occurred:  Your Hospital  Other Hospital  Both
41. a) Focal Intestinal Perforation:  Yes    No 
b) If Yes, Where Occurred:  Your Hospital  Other Hospital  Both
Sepsis and/or Meningitis, Late (after day 3 of life): (See Manual for N/A criteria)
42. a) Bacterial Pathogen:             Yes    No   N/A 
b) If Yes, Where Occurred:  Your Hospital  Other Hospital Both 
43. a) Coagulase Negative Staph:  Yes   No    N/A 
b) If Yes, Where Occurred:  Your Hospital  Other Hospital Both 
44. a) Fungal Infection:  Yes  No    N/A
b) If Yes, Where Occurred:  Your Hospital  Other Hospital Both 
45. Cystic Periventricular Leukomalacia:  Yes  No  N/A (see Manual for N/A criteria)
46. ROP:  a) Retinal Exam Done:  Yes No
b) If Yes, Worst Stage of ROP (0-5): _____
47. Major Birth Defect:      Yes    No
If Yes, enter codes:  _____   _____   _____   _____   ____
Include description for Codes 100, 504, 601, 605, 901, 902, 903, 904 & 907:
48. Enteral Feeding at Discharge:
 None   
 Human Milk Only
 Formula Only  
 Human milk in combination with either fortifier or formula
49. Oxygen and Monitor at Discharge:
a) Oxygen at Discharge:  Yes  No 
b) Monitor at Discharge:  Yes No
50. Initial Disposition (check only one):
 Home 
 Died 
 Transferred to another Hospital ( Complete Transfer and Readmission Form) 
 Still Hospitalized as of First Birthday 
51. Weight at Initial Disposition: _________ grams
52. Head Circumference at Initial Disposition (in cm to the nearest10th):










DISCHARGE FORM - For Infants Born in 2015 - PAGE 2
Center Number: ______ Network ID Number: Year of Birth: _______
5
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Rel 19.0 © 2014 Vermont Oxford Network, Inc. All Rights Reserved. 06/10/2014 
TRANSFER & READMISSION FORM - For Infants Born in 2015
Center Number: ________   Network ID Number: Year of Birth:  _____
Part A.  Complete for ALL Transferred Infants 
If an infant is transferred to another hospital, complete Items 54 - 56. Post Transfer Disposition (Item 56) refers to the 
infant's disposition upon leaving the "transferred to" hospital.  
54. Reason for Transfer: Growth/Discharge Planning  Medical/Diagnostic Services 
 Surgery ECMO  Chronic Care  Other 
55. Transfer Code of Center to which Infant Transferred: __________ (List available at http://www.vtoxford.org/transfers)
56. Post Transfer Disposition (check only one):
Home   Skip Parts B and C. Complete Part D.
 Transferred Again to Another Hospital (2nd Transfer) Skip Part B. Complete Parts C and D when data are available.
 Died Skip Parts B and C. Complete Part D.
 Readmitted to Any Location in Your Hospital  Complete Parts B and D (and C if applicable) when data are available.
 Still Hospitalized as of First Birthday Skip Parts B and C. Complete Part D. 
Part B.  Complete ONLY for Readmitted Infants 
If a patient is readmitted to your center after transferring once to another hospital without having been home, answer Items 
57 - 58. When infants are readmitted to your center, continue to update Items 18 - 20 on the 28 Day Form, and Items 22 –
49 on the Discharge Form based on all events at both hospitals until the date of Disposition after Readmission.  If your 
hospital participates in the Expanded Database and definition criteria are met, update Items S1.B, S1.C.1, S1.C.2, S2.A.1,
S2.A.2 and S2.C based on events that occur following transfer and readmission.
57. Disposition after Readmission (check only one):
 Home   Skip Part C. Complete Part D. 
 Died   Skip Part C. Complete Part D. 
 Transferred Again to Another Hospital Complete Parts C and D when data are available. 
 Still Hospitalized as of First Birthday    Skip Part C. Complete Part D. 
58. Weight at Disposition after Readmission:  _________ grams
Part C.  Complete ONLY for Infants Who Transferred More Than Once 
Answer Item 59 if an infant transferred from your center to another hospital and was then either (1) transferred again to 
another hospital, or (2) readmitted to your center and then transferred again to another hospital.  
59. Ultimate Disposition (check only one):
 Home    Complete Part D. 
 Died   Complete Part D.
 Still Hospitalized as of First Birthday Complete Part D.
Part D. Complete for ALL Transferred Infants
Complete Item 60 when the infant has been discharged Home, Died or is Still Hospitalized as of First Birthday, whichever 
comes first.
60. Total Length of Stay: ________day(s)    (Item L2 on Length of Stay Calculation Worksheet)
(Check Only One)
6
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Rel 19.0 Copyright © 2014  Vermont Oxford Network, Inc.   All Rights Reserved. 
   
VERMONT OXFORD NETWORK  
DELIVERY ROOM DEATH BOOKLET FOR INFANTS BORN IN 2015
Contents:
Page 1:  Patient Identification Worksheet 
Page 2:  Delivery Room Death Form 
W1. Patient’s Name: ________________________________________ 
W2. Mother’s Name: _________________________________________
W3. Patient’s Medical Record Number: ________________________________
W4. Date of Birth:  _____/_____/_____
MM          DD            YYYY
PLEASE DO NOT SUBMIT THIS WORKSHEET
Protected Health Care Information
DELIVERY ROOM DEATH 
PATIENT IDENTIFICATION WORKSHEET
Use the Delivery Room Death Booklet for eligible inborn infants who die in the delivery 
room or at any other location in your hospital within 12 hours of birth and prior to 
admission to the NICU. 
The Delivery Room Death Patient Identification Worksheet contains personal 
patient identifiers and must NOT be submitted to the Vermont Oxford Network. 
The Vermont Oxford Network does not accept protected health care 
information.  
Network ID Number: Center Number: _______
1
NPEC Very Low Birth Weight Neonatal Care 2015 050517 V2.indd   64 05/05/2017   11:55
 65
Rel 19.0 © 2014 Vermont Oxford Network, Inc. All Rights Reserved. 05/30/2014
DELIVERY ROOM DEATH FORM – For Infants Born in 2015
Center Number:  ________ Network ID Number:  Year of Birth:  _______
1. Birth Weight: ________ grams  
2. Gestational Age: a) Weeks _____ b) Days (0-6) _____
3. Died in Delivery Room:  Yes No (If NO, do not use this Form)
4. a) Location of Birth:  Inborn  Outborn (If OUTBORN, do not use this Form)
b and c:  Not Applicable 
5. Head Circumference at Birth (in cm to the nearest 10th):
6. Maternal Ethnicity/Race: (answer both a and b)
a) Ethnicity of Mother:  Hispanic    Not Hispanic 
b) Race of Mother:  Black or African American      White  Asian
 American Indian or Alaska Native  Native Hawaiian or Other Pacific Islander
 Other 
7. Prenatal Care:  Yes No
8. Antenatal Steroids:  Yes  No
9. Antenatal Magnesium Sulfate:  Yes  No
10. Chorioamnionitis:  Yes No
11.  Maternal Hypertension, Chronic or Pregnancy-Induced:  Yes No
12. Mode of Delivery:  Vaginal  Cesarean Section 
13. Sex of Infant:  Male  Female 
14. a) Multiple Gestation:  Yes No b) If Yes, Number of Infants Delivered:    ______
15. APGAR Scores: a) 1 minute _____ b) 5 minutes  _____
16. Initial Resuscitation: a) Oxygen:  Yes No
b) Face Mask Vent:  Yes No
c) Endotracheal Tube Vent:  Yes No
d) Epinephrine:  Yes   No
e) Cardiac Compression:  Yes No
 f) Nasal CPAP:  Yes No
17 – 23:  Not Applicable 
24. Surfactant Treatment:
a) Surfactant during Initial Resuscitation:  Yes   No  
b) Surfactant at Any Time:  Yes   No  (Part b must be answered “Yes” if Part a is “Yes”)
If Yes, Age at First Dose: c) hours ______ d) minutes (0-59) ______
25 – 46:  Not Applicable 
47. Major Birth Defect:  Yes   No    If Yes, enter codes    ______  ______  ______  ______  _______ 
Include description for Codes 100, 504, 601, 605, 901, 902, 903, 904 & 907: _________________________ 
____________________________________________________________________________________________ 
▪
48 – 60:  Not Applicable
If your center participates in the Expanded Database, answer Items S2. B.1 and S2. B.2 from the 
Supplemental Data Form.  Items S1.A. to S1.C. and Items S2.A and S2.C are not applicable.
S2. B. 1. Meconium Aspiration:    Yes      No
B. 2. Tracheal Suction for Meconium Attempted in the DR:      Yes      No N/A
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